Paclitaxel Treatment Options

A collection of 2016 research studies where Paclitaxel is the interventional treatment. These studies are located in the United States. Paclitaxel is used for conditions such as Breast Cancer, Ovarian Cancer and Non-Small Cell Lung Cancer.

Home

All Treatments

Paclitaxel

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

Featured Trial

Paid Clinical Studies Nationwide

Recruiting

Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.

Conditions:

Healthy

Healthy Volunteer Study

Learn More

* Compensation for time may be available

Featured Trial

Studying an Investigational Virus Vaccine

Recruiting

The main objectives of this study are to assess the safety and effectiveness of an investigational vaccine aimed at preventing norovirus, commonly known as the stomach flu. Participants will be randomly assigned to receive either the investigational vaccine or a placebo. Should you express interest, you will be contacted directly by the research site, which will provide further details and answer any questions you may have about study requirements, risks/benefits, and any compensation.

Conditions:

Healthy

Interested in vaccine studies

All Conditions

Preventative Trials

Learn More

Featured Trial

Type 2 Diabetes Clinical Trial

Recruiting

Can changing your breakfast improve your type 2 diabetes? If you have an HbA1C of 7.0% or higher, you are invited to participate in an online study at the University of Michigan.

Conditions:

Type 2 Diabetes

Diabetes Mellitus Type 2 in Obese

Diabetes Type Two

Type 2 Diabetes Mellitus

Diabete Type 2

Learn More

Featured Trial

Evaluating an Investigational Treatment for Hidradenitis Suppurativa

Recruiting

The main objectives of this Phase 2 study are to evaluate the safety and effectiveness of an investigational medication in adults with moderate to severe hidradenitis suppurativa (HS), a chronic skin condition. Participants will be randomly assigned to receive the investigational treatment or a placebo. Should you express interest, the research site will contact you directly to provide further details and address any questions you may have about study requirements, risks/benefits, and compensation.

Conditions:

All Conditions

Hidradenitis suppurativa (Skin disorder)

Dermatology

Learn More

PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples

NCT04683315

Recruiting

This is an open-label, phase II study in patients with resectable and borderline resectable pancreatic cancer.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/19/2024

Locations: HonorHealth Medical Group, Scottsdale, Arizona +1 locations

Conditions: Pancreatic Cancer

Learn More ›

A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)

NCT00889382

Completed

This is a multi-center, randomized, open-label, phase 1/2 study of continuous weekly paclitaxel and escalating doses of intermittent or continuous OSI-906 in patients with recurrent/relapsed ovarian and other solid tumors.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/18/2024

Locations: Mayo Clinic, Scottsdale, Arizona +45 locations

Mayo Clinic, Scottsdale, Arizona

Department of Obstetrics and Gynecology, University of California, Irvine, Orange, California

Horizon Oncology Center, Lafayette, Indiana

Ochsner Clinic Foundation, New Orleans, Louisiana

Morristown Memorial Hospital, Morristown, New Jersey

Blumenthal Cancer Center - Main, Charlotte, North Carolina

Duke University Medical Center, Durham, North Carolina

University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma

WestMead Hospital, WestMead, New South Wales

Mater Adult Hospital, South Brisbane, Queensland

Royal Adelaide Hospital, North Terrace, South Australia

Launceston General Hospital, Launceston, Tasmania

Frankston Hospital, Frankston, Victoria

Border Medical Oncology, Wodonga, Victoria

St. John of God Hospital, Bunbury, Bunbury, Western Australia

Sir Charles Gairdner Hospital, Perth, Western Australia

St. John of Gog Hospital, Subiaco, Subiaco, Western Australia

Juravinski Cancer Center, Hamilton, Ontario

Princess Margaret Hospital, Toronto, Ontario

McGill University, Montreal, Quebec

University Hospital Hradec Kralove, Kralove, Not set

University Hospital Ostrava, Ostrava- Poruba, Not set

General University Hospital, Department of Obstetrics and Gynecology, Prague, Not set

Universitaria di Bologna Policlinico, Bologna, Not set

Ospedale di Carpi, AUSL di Modena, Carpi, Not set

Instituto Europeo di Oncologia, Milan, Not set

Oncology IDI- IRCSS, Roma, Not set

III Oddzial Onkologii Ginekologicznej, Lublin, Not set

Oddzial Radioterapii, Poznan, Not set

Klinika Onkologii AM w Poznaniu, Poznan, Not set

Institutul Oncologic Prof. Dr. Ion. Chiricuta Sectia de Oncologie Medicala, Cluj Napoca, Not set

Institutul Oncologic Prof. Dr. Ion. Chiricuta Sectia Radiologie, Cluj Napoca, Not set

Oncology Medical Centre SCM, Iasi, Not set

Clinical Caunty Hospital Mures, Mures, Not set

Central Clinical Hospital, Moscow, Not set

Moscow City Oncology Hospital, Moscow, Not set

State Institution Medical Radiology Scientific Center, Obninsk, Not set

Sity Clinical Oncology, St. Petersburg, Not set

Ospedale San Giovanni, Bellinzona, Not set

Drug Development Unit Royal Mardsen NHS Foundation Trust, Sutton, Surrey

Royal Marsden Hospital, London, Not set

University College Hospital, London, Not set

The Christie NHS Foundation Trust, Manchester, Not set

Mount Vernon Cancer Center, Northwood, Not set

Churchill Hospital, Oxford, Not set

Christie NHS Foundation Trust, Withington, Not set

Conditions: Ovarian Cancer, Solid Tumors

Learn More ›

HOT: HIPEC in Ovarian Cancer as Initial Treatment

NCT02124421

Active Not Recruiting

Community hospital based phase II (prospective randomized) study to evaluate the toxicity of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in newly diagnosed, otherwise untreated, advanced stage (stage III/IV) epithelial ovarian, fallopian tube, and primary peritoneal cancer.

Gender:

FEMALE

Ages:

Between 18 years and 80 years

Trial Updated:

11/18/2024

Locations: Mercy Medical Center, Baltimore, Maryland

Conditions: Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma, Ovarian Carcinoma, Fallopian Tube Carcinoma

Learn More ›

An Investigational Immuno-therapy Trial of Nivolumab, or Nivolumab Plus Ipilimumab, or Nivolumab Plus Platinum-doublet Chemotherapy, Compared to Platinum Doublet Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC)

NCT02477826

Completed

The purpose of this study is to show that Nivolumab, or Nivolumab plus Ipilimumab, or Nivolumab plus Platinum-Doublet Chemotherapy improves progression free survival and/or overall survival compared with chemotherapy in patients with advanced lung cancer.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/16/2024

Locations: Southern Cancer Center, Inc., Mobile, Alabama +289 locations

Southern Cancer Center, Inc., Mobile, Alabama

Local Institution - 0017, San Francisco, California

Local Institution - 0021, New Haven, Connecticut

Local Institution - 0001, Atlanta, Georgia

Local Institution - 0013, Marietta, Georgia

Local Institution - 0004, Lexington, Kentucky

Local Institution - 0115, Saint Louis, Missouri

Local Institution - 0005, Buffalo, New York

Local Institution - 0019, New York, New York

Local Institution - 0014, Cleveland, Ohio

Local Institution - 0009, Columbus, Ohio

Local Institution - 0007, Allentown, Pennsylvania

Local Institution - 0075, Langhorne, Pennsylvania

Local Institution - 0299, Philadelphia, Pennsylvania

Local Institution - 0012, Philadelphia, Pennsylvania

Local Institution - 0015, Sayre, Pennsylvania

Local Institution - 0008, Charleston, South Carolina

Local Institution - 0080, Greenville, South Carolina

Local Institution - 0010, Greenville, South Carolina

Local Institution - 0020, Nashville, Tennessee

Local Institution - 0306, Dallas, Texas

Local Institution - 0003, Dallas, Texas

Local Institution - 0102, Houston, Texas

Local Institution - 0011, Salt Lake City, Utah

Local Institution - 0074, Kennewick, Washington

Local Institution - 0170, Berazategui, Buenos Aires

Local Institution - 0171, Capital Federal, Buenos Aires

Local Institution - 0172, Ciudad Autonoma De Buenos Aire, Buenos Aires

Local Institution - 0176, Ciudad de Buenos Aires, Buenos Aires

Local Institution - 0296, Mar Del Plata, Buenos Aires

Local Institution - 0177, Viedma, RIO Negro

Local Institution - 0130, San Miguel de Tucuman, Tucuman

Local Institution - 0268, Cordoba, Not set

Local Institution - 0272, Córdoba, Not set

Local Institution - 0297, Córdoba, Not set

Local Institution - 0182, Garran, Australian Capital Territory

Local Institution - 0301, Blacktown, New South Wales

Local Institution - 0300, Gosford, New South Wales

Local Institution - 0045, Brisbane, Queensland

Local Institution - 0046, Elizabeth Vale, South Australia

Local Institution - 0043, Clayton, Victoria

Local Institution - 0042, Fitzroy, Victoria

Local Institution - 0180, Perth, Western Australia

Local Institution - 0040, Murdoch, Not set

Local Institution - 0183, North Tamworth, Not set

Local Institution - 0241, Graz, Not set

Local Institution - 0240, Vienna, Not set

Local Institution - 0239, Wels, Not set

Local Institution - 0121, Roeselare, West-Vlaanderen

Local Institution - 0030, Edegem, Not set

Local Institution - 0031, Gent, Not set

Local Institution - 0034, Gilly, Not set

Local Institution - 0117, Hasselt, Not set

Local Institution - 0033, Sint Niklaas, Not set

Local Institution - 0125, Salvador, Bahia

Local Institution - 0124, Ijui, RIO Grande DO SUL

Local Institution - 0123, Porto Alegre, Rio Grande Do Sul

Local Institution - 0127, Barretos, Sao Paulo

Local Institution - 0129, Rio De Janeiro, Not set

Local Institution - 0144, Sao Paulo, Not set

Local Institution - 0126, Sao Paulo, Not set

Local Institution - 0128, Sao Paulo, Not set

Local Institution - 0103, Edmonton, Alberta

Local Institution - 0290, St. John's, Newfoundland and Labrador

Local Institution - 0104, London, Ontario

Local Institution - 0122, Montreal, Quebec

Local Institution - 0106, Quebec City, Quebec

Local Institution - 0107, Rimouski, Quebec

Local Institution - 0291, Sherbrooke, Quebec

Local Institution - 0292, Trois-Rivieres, Quebec

Local Institution - 0302, Quebec, Not set

Local Institution - 0173, Santiago, Metropolitana

Local Institution - 0131, Santiago, Región Metropolitana De Santiago

Local Institution - 0174, Vina Del Mar, Valparaiso

Local Institution - 0380, Hefei, Anhui

Local Institution - 0313, Beijing, Beijing

Local Institution - 0315, Beijing, Beijing

Local Institution - 0316, Beijing, Beijing

Local Institution - 0314, Beijing, Beijing

Local Institution - 0365, Chongqing, Chongqing

Local Institution - 0364, Chongqing, Chongqing

Local Institution - 0378, Chongqing, Chongqing

Local Institution - 0322, Guangzhou, Guangdong

Local Institution - 0372, Guangzhou, Guangdong

Local Institution - 0319, Guanzhou, Guangdong

Local Institution - 0323, Haikou, Hainan

Local Institution - 0325, Haerbin, Heilongjiang

Local Institution - 0324, Zhengzhou, Henan

Local Institution - 0379, Zhengzhou, Henan

Local Institution - 0375, Wuhan, Hubei

Local Institution - 0362, Changsha, Hunan

Local Institution - 0347, Nanchang, Jiangxi

Local Institution - 0329, Changchun, Jilin

Local Institution - 0361, Changchun, Jilin

Local Institution - 0359, Shenyang, Liaoning

Local Institution - 0371, Xi'an, Shaanxi

Local Institution - 0333, Xi'an, Shan3xi

Local Institution - 0360, Qingdao, Shandong

Local Institution - 0334, Shanghai, Shanghai

Local Institution - 0376, Chengdu, Sichuan

Local Institution - 0373, Tianjin, Tianjin

Local Institution - 0340, Urumqi, Xinjiang

Local Institution - 0343, Hangzhou, Zhejiang

Local Institution - 0370, Hangzhou, Zhejiang

Local Institution - 0342, Hangzhou, Zhejiang

Local Institution - 0328, Changsha, Not set

Local Institution - 0341, Hangzhou, Not set

Local Institution - 0345, Kunming, Not set

Local Institution - 0336, Shanghai, Not set

Local Institution - 0337, Shanghai, Not set

Local Institution - 0374, Shantou, Not set

Local Institution - 0273, Pereira, Risaralda

Local Institution - 0237, Bogota, Not set

Local Institution - 0238, Bogota, Not set

Local Institution - 0282, Medellin, Not set

Local Institution - 0112, Hradec Kralove, Not set

Local Institution - 0113, Olomouc, Not set

Local Institution - 0111, Praha 4, Not set

Local Institution - 0232, Pribram, Not set

Local Institution - 0270, Oulu, Not set

Local Institution - 0271, Turku, Not set

Local Institution - 0222, Bron, Rhône

Local Institution - 0216, ANGERS Cedex 2, Not set

Local Institution - 0229, Besançon Cedex, Not set

Local Institution - 0283, Caen, Not set

Local Institution - 0218, Creteil, Not set

Local Institution - 0228, Limoges, Not set

Local Institution - 0215, Marseille Cedex 20, Not set

Local Institution - 0230, Paris, Not set

Local Institution - 0227, Pessac, Not set

Local Institution - 0223, Rennes, Not set

Local Institution - 0225, Rouen, Not set

Local Institution - 0221, Saint Priest En Jarez, Not set

Local Institution - 0217, Saint-herblain Cedex, Not set

Local Institution - 0224, Strasbourg, Not set

Local Institution - 0226, Toulon, Not set

Local Institution - 0231, Magdeburg, Sachsen-Anhalt

Local Institution - 0213, Bad Berka, Not set

Local Institution - 0208, Berlin, Not set

Local Institution - 0205, Essen, Not set

Local Institution - 0210, Frankfurt, Not set

Local Institution - 0211, Gera, Not set

Local Institution - 0203, Grosshansdorf, Not set

Local Institution - 0209, Halle, Not set

Local Institution - 0202, Heidelberg, Not set

Local Institution - 0214, Hemer, Not set

Local Institution - 0206, Immenstadt, Not set

Local Institution - 0204, Muenchen, Not set

Local Institution - 0201, Stuttgart, Not set

Local Institution - 0212, Wiesbaden, Not set

Local Institution - 0094, Athens, Attikí

Local Institution - 0095, Heraklion, Not set

Local Institution - 0190, Neo Faliro, Not set

Local Institution - 0101, Thessaloniki, Not set

Local Institution - 0025, Budapest, Not set

Local Institution - 0024, Budapest, Not set

Local Institution - 0026, Matrahaza, Not set

Local Institution - 0054, Dublin 8, Dublin

Local Institution - 0053, Beaumont, Not set

Local Institution - 0055, Galway, Not set

Local Institution - 0100, Limerick, Not set

Local Institution - 0187, Jerusalem, Not set

Local Institution - 0186, Kfar-saba, Not set

Local Institution - 0185, Petach Tikva, Not set

Local Institution - 0184, Tel-hashomer, Not set

Local Institution - 0188, Zerifin, Not set

Local Institution - 0083, Milan, Lombardia

Azienda Ospedaliera Moscati, Avellino, Not set

Local Institution - 0179, Bergamo, Not set

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola, Bologna, Not set

Local Institution - 0084, Livorno, Not set

Policlinico G. Martino, Messina, Not set

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Not set

Istituto Nazionale Tumori Fondazione Pascale, Napoli, Not set

Local Institution - 0087, Perugia, Not set

Ospedale Santa Maria delle Croci, Ravenna, Not set

Ifo-Istituto Regina Elena, Roma, Not set

Local Institution - 0089, Roma, Not set

Local Institution - 0085, Terni, Not set

Local Institution - 0153, Nagoya-shi, Aichi

Local Institution - 0152, Nagoya, Aichi

Local Institution - 0148, Kashiwa-shi, Chiba

Local Institution - 0159, Matsuyama, Ehime

Local Institution - 0160, Fukuoka-shi, Fukuoka

Local Institution - 0259, Kurume-shi, Fukuoka

Local Institution - 0255, Ota-shi, Gunma

Local Institution - 0258, Hiroshima-shi, Hiroshima

Local Institution - 0163, Sapporo-shi, Hokkaido

Local Institution - 0253, Sapporo-shi, Hokkaido

Local Institution - 0252, Akashi-shi, Hyogo

Local Institution - 0156, Kobe-shi, Hyogo

Local Institution - 0146, Kanazawa-shi, Ishikawa

Local Institution - 0161, Yokohama-shi, Kanagawa

Local Institution - 0150, Yokohama-Shi, Kanagawa

Local Institution - 0275, Natori-shi, Miyagi

Local Institution - 0254, Sendai-shi, Miyagi

Local Institution - 0145, Sendai-shi, Miyagi

Local Institution - 0164, Niigata-shi, Niigata

Local Institution - 0158, Kurashiki-shi, Okayama

Local Institution - 0155, Hirakata-shi, Osaka

Local Institution - 0154, Osaka-shi, Osaka

Local Institution - 0251, Osakasayama-shi, Osaka

Local Institution - 0257, Takatsuki-shi, Osaka

Local Institution - 0353, Hidaka-shi, Saitama

Local Institution - 0256, Kitaadachi-gun, Saitama

Local Institution - 0151, Sunto-gun, Shizuoka

Local Institution - 0147, Chuo-ku, Tokyo

Local Institution - 0149, Koto-ku, Tokyo

Local Institution - 0278, Shinjuku-ku, Tokyo

Local Institution - 0157, Wakayama-shi, Wakayama

Local Institution - 0354, Ube-shi, Yamaguchi

Local Institution - 0260, Chiba, Not set

Local Institution - 0165, Okayama, Not set

Local Institution - 0162, Tokyo, Not set

Local Institution - 0136, Seongnam-si, Kyǒnggi-do

Local Institution - 0249, Cheongju-si, Not set

Local Institution - 0133, Gangnam-gu, Not set

Local Institution - 0132, Seoul, Not set

Local Institution - 0135, Seoul, Not set

Local Institution - 0287, Beirut, Not set

Local Institution - 0286, Beirut, Not set

Local Institution - 0196, Df, Distrito Federal

Local Institution - 0193, Mexico, Distrito Federal

Local Institution - 0198, Cuautitlan, Estado DE Mexico

Local Institution - 0197, Guadalajara, Jalisco

Local Institution - 0191, Zapopan, Jalisco

Local Institution - 0267, Morelia, Michoacan

Local Institution - 0277, Monterrey, Nuevo Leon

Local Institution - 0303, Merida, Yucatán

Local Institution - 0192, Chihuahua, Not set

Local Institution - 0195, San Luis Potosi, Not set

Local Institution - 0236, San Luis Potosi, Not set

Local Institution - 0194, Toluca, Not set

Local Institution - 0036, Amsterdam, Not set

Local Institution - 0189, Amsterdam, Not set

Local Institution - 0169, Breda, Not set

Local Institution - 0037, Rotterdam, Not set

Local Institution - 0039, Veldhoven, Not set

Local Institution - 0262, Lima, Not set

Local Institution - 0263, Lima, Not set

Local Institution - 0350, Lima, Not set

Local Institution - 0261, Lima, Not set

Local Institution - 0351, Lima, Not set

Local Institution - 0060, Bydgoszcz, Not set

Local Institution - 0058, Gdansk, Not set

Local Institution - 0063, Gdynia, Not set

Local Institution - 0072, Gliwice, Not set

Local Institution - 0057, Lodz, Not set

Local Institution - 0059, Warszawa, Not set

Local Institution - 0070, Wroclaw, Not set

Local Institution - 0167, Craiova, Not set

Local Institution - 0250, Floresti, Not set

Local Institution - 0166, Romania, Not set

Local Institution - 0284, Sector 2, Not set

Local Institution - 0137, Chelyabinsk, Not set

Local Institution - 0142, Kazan, Not set

Local Institution - 0022, Moscow, Not set

Local Institution - 0049, Saint-Petersburg, Not set

Local Institution - 0028, St. Petersburg, Not set

Local Institution - 0027, St. Petersburg, Not set

Local Institution - 0143, Ufa, Not set

Local Institution - 0264, Pretoria, Gauteng

Local Institution - 0234, Sandton, Gauteng

Local Institution - 0233, Saxonwold, Johannesburg, Gauteng

Local Institution - 0305, Vereeniging, Not set

Local Institution - 0064, Majadahonda, Madrid

Local Institution - 0066, Barcelona, Not set

Local Institution - 0067, Barcelona, Not set

Local Institution - 0065, Madrid, Not set

Local Institution - 0069, Sevilla, Not set

Local Institution - 0068, Valencia, Not set

Local Institution - 0243, Basel, Not set

Local Institution - 0246, Chur, Not set

Local Institution - 0244, Lausanne, Not set

Local Institution - 0245, Winterthur, Not set

Local Institution - 0139, Taichung, Not set

Local Institution - 0138, Taipei, Not set

Local Institution - 0140, Taipei, Not set

Local Institution - 0310, Taipei, Not set

Local Institution - 0141, Taoyuan city, Not set

Local Institution - 0266, Middlesborough, Cleveland

Local Institution - 0098, London, Greater London

Local Institution - 0099, Southampton, Hampshire

Local Institution - 0118, Leicester, Leicestershire

Local Institution - 0265, Birmingham, Not set

Local Institution - 0051, Cambridgeshire, Not set

Local Institution - 0109, Edinburgh, Not set

Local Institution - 0097, London, Not set

Local Institution - 0050, London, Not set

Local Institution - 0119, Surrey, Not set

Conditions: Non-Small Cell Lung Cancer

Learn More ›

Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036)

NCT03740165

Active Not Recruiting

The purpose of this study is to assess the efficacy and safety of treatment with carboplatin/paclitaxel\* PLUS pembrolizumab (MK-3475) and maintenance olaparib (MK-7339) in women with epithelial ovarian cancer (EOC), fallopian tube cancer, or primary peritoneal cancer. The primary study hypotheses are that the combination of pembrolizumab plus carboplatin/paclitaxel\* followed by continued pembrolizumab and maintenance olaparib is superior to carboplatin/paclitaxel alone with respect to Progres... Read More

Gender:

FEMALE

Ages:

18 years and above

Trial Updated:

11/15/2024

Locations: University of Alabama at Birmingham (UAB) ( Site 0036), Birmingham, Alabama +226 locations

University of Alabama at Birmingham (UAB) ( Site 0036), Birmingham, Alabama

University of Arizona Cancer Center ( Site 0074), Tucson, Arizona

Disney Family Cancer Center ( Site 0042), Burbank, California

Kaiser Permanente Oncology Clinical Trial -Oakland ( Site 0077), Oakland, California

Kaiser Permanente Oncology Clinical Trials-Roseville ( Site 0084), Roseville, California

Kaiser Permanente Oncology Clinical Trials-Sacramento ( Site 0083), Sacramento, California

Kaiser Permanente Oncology Clinical Trial - San Francisco ( Site 0078), San Francisco, California

Kaiser Permanente Oncology Clinical Trial - Santa Clara ( Site 0079), Santa Clara, California

Kaiser Permanente N. CA Regional Oncology Clinical Trials ( Site 0008), Vallejo, California

Kaiser Permanente Oncology Clinical Trial - Walnut Creek ( Site 0080), Walnut Creek, California

Smilow Cancer Center at Yale-New Haven ( Site 0057), New Haven, Connecticut

Sarasota Memorial Hospital ( Site 0023), Sarasota, Florida

Emory School of Medicine ( Site 0053), Atlanta, Georgia

Northeast Georgia Medical Center ( Site 0029), Gainesville, Georgia

Memorial Health University Medical Center ( Site 0011), Savannah, Georgia

Rush University Medical Center ( Site 0019), Chicago, Illinois

University of Chicago ( Site 0049), Chicago, Illinois

Dr. Sudarshan K. Sharma, LTD ( Site 0061), Hinsdale, Illinois

Saint Vincent Hospital and Health Center ( Site 0012), Indianapolis, Indiana

University of Iowa Hospital and Clinics ( Site 0005), Iowa City, Iowa

University of Kentucky ( Site 0045), Lexington, Kentucky

Weinberg Cancer Institute at Franklin Square ( Site 0035), Baltimore, Maryland

Saint Dominic - Jackson Memorial Hospital ( Site 0072), Jackson, Mississippi

Washington University - School of Medicine ( Site 0062), Saint Louis, Missouri

Nebraska Methodist Hospital ( Site 0063), Omaha, Nebraska

Dartmouth Hitchcock Medical Center ( Site 0024), Lebanon, New Hampshire

MD Anderson Cancer Center at Cooper ( Site 0067), Camden, New Jersey

Holy Name Medical Center ( Site 0037), Teaneck, New Jersey

Northwell Health- Monter Cancer Center ( Site 0075), Lake Success, New York

Sanford Roger Maris Cancer Center ( Site 0082), Fargo, North Dakota

Miami Valley Hospital [Dayton, OH] ( Site 0073), Centerville, Ohio

Oncology/Hematology Care Clinical Trials, LLC ( Site 8001), Cincinnati, Ohio

The Bing Cancer Center ( Site 0044), Columbus, Ohio

OSU Wexner Medical Center ( Site 0076), Hilliard, Ohio

Women and Infants Hospital [Providence, RI] ( Site 0039), Providence, Rhode Island

Sanford Gynecology Oncology ( Site 0004), Sioux Falls, South Dakota

Texas Oncology, P.A. - Bedford ( Site 8005), Bedford, Texas

Texas Oncology-Dallas Presbyterian Hospital ( Site 8004), Dallas, Texas

Parkland Hospital ( Site 0081), Dallas, Texas

UT Southwestern Medical Center ( Site 0046), Dallas, Texas

Texas Oncology, P.A. Texas Oncology-Tyler ( Site 8006), Tyler, Texas

Virginia Cancer Specialists, PC ( Site 8003), Gainesville, Virginia

MEDICAL COLLEGE OF WISCONSIN ( Site 0064), Milwaukee, Wisconsin

St George Hospital ( Site 2207), Kogarah, New South Wales

Cairns and Hinterland Hospital and Health Service ( Site 2201), Cairns, Queensland

Ballarat Health Services ( Site 2202), Ballarat, Victoria

Monash Health ( Site 2204), Clayton, Victoria

Sunshine Hospital. ( Site 2205), St Albans, Victoria

Imelda Ziekenhuis Bonheiden ( Site 0301), Bonheiden, Antwerpen

UZ Leuven Campus Gasthuisberg ( Site 0306), Leuven, Antwerpen

Cliniques Universitaires Saint-Luc ( Site 0312), Brussels, Bruxelles-Capitale, Region De

Grand Hopital de Charleroi ( Site 0302), Charleroi, Hainaut

CHU de Liege ( Site 0310), Liège, Liege

Jessa Ziekenhuis ( Site 0309), Hasselt, Limburg

Centre Hospitalier de l'Ardenne ( Site 0303), Libramont, Luxembourg

AZ Maria Middelares Gent ( Site 0300), Gent, Oost-Vlaanderen

UZ Gent ( Site 0307), Gent, Oost-Vlaanderen

Instituto do Cancer do Ceara ( Site 2707), Fortaleza, Ceara

Hospital Araujo Jorge Associacao de Combate ao Cancer de Goias ( Site 2708), Goiania, Goias

Hospital Erasto Gaertner ( Site 2716), Curitiba, Parana

Hospital de Caridade de Ijui ( Site 2712), Ijui, Rio Grande Do Sul

Hospital Bruno Born ( Site 2704), Lajeado, Rio Grande Do Sul

Hospital Nossa Senhora Da Conceicao ( Site 2703), Porto Alegre, Rio Grande Do Sul

Instituto Nacional de Cancer Hospital do Cancer II ( Site 2700), Rio de Janeiro, Not set

Instituto do Cancer do Estado de Sao Paulo - ICESP ( Site 2714), Sao Paulo, Not set

Clinica de Pesquisas e Ctro de Estudos Onc. Ginecol. e Mamaria Ltda ( Site 2706), Sao Paulo, Not set

Real e Benemerita Associacao Portuguesa de Beneficencia ( Site 2710), Sao Paulo, Not set

Tom Baker Cancer Centre ( Site 0200), Calgary, Alberta

Kingston Health Sciences Centre ( Site 0207), Kingston, Ontario

The Credit Valley Hospital ( Site 0206), Mississauga, Ontario

Princess Margaret Hospital.. ( Site 0202), Toronto, Ontario

CIUSSS du Saguenay-Lac-St-Jean ( Site 0218), Chicoutimi, Quebec

CIUSSS de l Est de L Ile de Montreal - Hopital Maisonneuve-Rosemont ( Site 0219), Montreal, Quebec

Centre Hospitalier de l Universite de Montreal - CHUM ( Site 0208), Montreal, Quebec

Royal Victoria Hospital McGill University Health Centre ( Site 0211), Montreal, Quebec

Centro Investigación del Cáncer James Lind ( Site 2810), Temuco, Araucania

Centro de Investigacion y desarrollo Oncologico SpA - CIDO SpA ( Site 2808), Temuco, Araucania

Fundacion Arturo Lopez Perez FALP ( Site 2800), Santiago, Region M. De Santiago

Sociedad Oncovida S.A. ( Site 2807), Santiago, Region M. De Santiago

Iram Cancer Research ( Site 2809), Santiago, Region M. De Santiago

Pontificia Universidad Catolica de Chile ( Site 2805), Santiago, Region M. De Santiago

Oncocentro ( Site 2801), Vina del Mar, Valparaiso

Centro Oncologico Antofagasta ( Site 2804), Antofagasta, Not set

Biomelab S A S ( Site 2900), Barranquilla, Atlantico

Sociedad de Oncología Y Hematología del Cesar S.A.S. ( Site 2913), Valledupar, Cesar

Oncomedica S.A. ( Site 2911), Monteria, Cordoba

Instituto Nacional de Cancerologia E.S.E ( Site 2910), Bogota, Distrito Capital De Bogota

Clinica Colsanitas S.A. Sede Clinica Universitaria Colombia ( Site 2912), Bogota, Distrito Capital De Bogota

Centro Medico Imbanaco de Cali S.A ( Site 2909), Cali, Valle Del Cauca

Hemato Oncologos S.A. ( Site 2906), Cali, Valle Del Cauca

Fakultni nemocnice Brno ( Site 0404), Brno, Brno-mesto

Fakultni nemocnice Ostrava ( Site 0403), Ostrava-Poruba, Moravskoslezsky Kraj

Vseobecna fakultni nemocnice v Praze ( Site 0400), Praha, Praha, Hlavni Mesto

Nemocnice Na Bulovce ( Site 0401), Praha, Praha, Hlavni Mesto

Fakultni nemocnice Olomouc ( Site 0402), Olomouc, Not set

Hopital Prive Jean Mermoz ( Site 0607), Lyon, Auvergne

Centre Paul Strauss ( Site 0615), Strasbourg, Bas-Rhin

Hopital de la Timone ( Site 0617), Marseille, Bouches-du-Rhone

CHU de Brest -Site Hopital Morvan ( Site 0616), Brest, Bretagne

Institut de Cancerologie du Gard - CHU Caremeau ( Site 0610), Nimes, Gard

Institut de Cancerologie Lucien Neuwirth ( Site 0613), Saint-Priest-en-Jarez, Loire

Centre D Oncologie de Gentilly ( Site 0609), Nancy, Meurthe-et-Moselle

Institut Gustave Roussy ( Site 0600), Villejuif, Val-de-Marne

Hopital Tenon ( Site 0612), Paris, Not set

Marienhospital Stuttgart Vincenz von Paul Kliniken gGmbH ( Site 0707), Stuttgart, Baden-Wurttemberg

Klinikum Rechts der Isar. Technischen Universitaet Muenchen ( Site 0710), Muenchen, Bayern

Uniklinik RWTH Aachen ( Site 0718), Aachen, Nordrhein-Westfalen

Gynaekologisches Zentrum ( Site 0712), Bonn, Nordrhein-Westfalen

Klinikum Dortmund gGmbH ( Site 0717), Dortmund, Nordrhein-Westfalen

Universitaetsklinikum Duesseldorf ( Site 0704), Duesseldorf, Nordrhein-Westfalen

HELIOS Klinikum Krefeld ( Site 0715), Krefeld, Nordrhein-Westfalen

Universitaetsklinikum Muenster ( Site 0720), Muenster, Nordrhein-Westfalen

Caritas Klinikum Saarbruecken St. Theresia ( Site 0702), Saarbruecken, Saarland

Klinikum Chemnitz gGmbH ( Site 0711), Chemnitz, Sachsen

Staedtisches Krankenhaus Kiel GmbH ( Site 0709), Kiel, Schleswig-Holstein

Charite Campus Virchow-Klinikum - CVK ( Site 0700), Berlin, Not set

Pecsi Tudomanyegyetem Klinikai Kozpont ( Site 0805), Pecs, Baranya

Borsod-Abauj-Zemplen Megyei Korhaz es Egyetemi Oktato Korhaz ( Site 0802), Miskolc, Borsod-Abauj-Zemplen

Orszagos Onkologiai Intezet ( Site 0800), Budapest, Not set

Uzsoki Utcai Korhaz ( Site 0803), Budapest, Not set

Debreceni Egyetem Klinikai Kozpont ( Site 0801), Debrecen, Not set

Soroka Medical Center ( Site 1006), Beer-Sheva, Not set

Hillel Yaffe Medical Center ( Site 1011), Hadera, Not set

Carmel Medical Center ( Site 1007), Haifa, Not set

Rambam Medical Center ( Site 1002), Haifa, Not set

Edith Wolfson Medical Center ( Site 1003), Holon, Not set

Shaare Zedek Medical Center ( Site 1005), Jerusalem, Not set

Rabin Medical Center ( Site 1004), Petah Tikva, Not set

Chaim Sheba Medical Center ( Site 1000), Ramat Gan, Not set

Sourasky Medical Center ( Site 1001), Tel Aviv, Not set

IRCCS Giovanni Paolo II. Ospedale Oncologico ( Site 1108), Bari, Abruzzo

Istituto Europeo di Oncologia ( Site 1100), Milano, Lombardia

A.O.U. Citta della Salute e della Scienza di Torino ( Site 1104), Torino, Piemonte

Istituto Oncologico Veneto IRCCS ( Site 1113), Padova, Veneto

Sacro Cuore di Gesu Fatebenefratelli ( Site 1112), Benevento, Not set

Ospedale Cannizzaro ( Site 1110), Catania, Not set

ASST Lecco. Ospedale A. Manzoni ( Site 1101), Lecco, Not set

Fondazione IRCCS Istituto Nazionale dei Tumori di Milano ( Site 1115), Milano, Not set

A.O.U. Federico II di Napoli ( Site 1107), Napoli, Not set

Azienda Ospedaliera Policlinico Umberto I ( Site 1111), Roma, Not set

Policlinico Universitario Gemelli ( Site 1105), Roma, Not set

Presidio Ospedaliero Santa Chiara ( Site 1109), Trento, Not set

A.O. Univ. S. M. della Misericordia ( Site 1114), Udine, Not set

National Cancer Center Hospital East ( Site 2602), Kashiwa, Chiba

National Hospital Organization Shikoku Cancer Center ( Site 2601), Matsuyama, Ehime

Ehime University Hospital ( Site 2600), Toon, Ehime

Gunma Prefectural Cancer Center ( Site 2609), Ota, Gunma

Hokkaido University Hospital ( Site 2607), Sapporo, Hokkaido

Iwate Medical University Hospital ( Site 2606), Shiwa-gun, Iwate

St. Marianna University School of Medicine Hospital ( Site 2613), Kawasaki, Kanagawa

University of the Ryukyus Hospital ( Site 2616), Nakagami-gun, Okinawa

Saitama Medical University International Medical Center ( Site 2604), Hidaka, Saitama

Saitama Cancer Center ( Site 2614), Kitaadachi-gun, Saitama

National Defense Medical College Hospital ( Site 2608), Tokorozawa, Saitama

Kyorin University Hospital ( Site 2610), Mitaka, Tokyo

Kagoshima City Hospital ( Site 2612), Kagoshima, Not set

Niigata Cancer Center Hospital ( Site 2618), Niigata, Not set

Osaka International Cancer Institute ( Site 2617), Osaka, Not set

National Cancer Center Hospital ( Site 2605), Tokyo, Not set

Seoul National University Bundang Hospital ( Site 2404), Seongnam-si, Kyonggi-do

Seoul National University Hospital ( Site 2403), Seoul, Not set

Severance Hospital Yonsei University Health System ( Site 2400), Seoul, Not set

Asan Medical Center ( Site 2402), Seoul, Not set

Samsung Medical Center ( Site 2401), Seoul, Not set

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie (, Warszawa, Mazowieckie

Bialostockie Centrum Onkologii ( Site 1412), Bialystok, Podlaskie

Szpitale Pomorskie Sp. z o.o. ( Site 1407), Gdynia, Pomorskie

Narodowy Instytut Onkologii - Oddzial w Gliwicach ( Site 1406), Gliwice, Slaskie

Swietokrzyskie Centrum Onkologii SPZOZ ( Site 1410), Kielce, Swietokrzyskie

Szpital Kliniczny im. Przemienienia Panskiego Uniwersytetu Medycznego im. K. Marcinkowskiego w Pozna, Poznan, Wielkopolskie

Arkhangelsk Clinical Oncological Dispensary ( Site 1508), Arkhangelsk, Arkhangel Skaya Oblast

Republican Clinical Oncology Dispensary of Republic of Bashkortostan ( Site 1507), Ufa, Baskortostan, Respublika

A. Tsyb Medical Radiological Research Center ( Site 1513), Obninsk, Kaluzskaja Oblast

FSBI National Medical Oncology Research Center n.a. N.N. Blokhina ( Site 1500), Moscow, Moskva

FSCC of Special Types of Med. Care and Technologies ( Site 1503), Moscow, Moskva

Medical Rehabilitation Center ( Site 1502), Moscow, Moskva

City Clinical Oncology Center ( Site 1505), Saint Petersburg, Sankt-Peterburg

National Medical Research Center of Oncology N.A. N.N. Petrov ( Site 1504), Saint-Petersburg, Sankt-Peterburg

Republican Clinical Oncology Dispensary of Tatarstan MoH ( Site 1509), Kazan, Tatarstan, Respublika

Cancer Care Langenhoven Drive Oncology Centre ( Site 1701), Port Elizabeth, Eastern Cape

Groote Schuur Hospital ( Site 1704), Cape Town, Gauteng

Wits Clinical Research ( Site 1702), Johannesburg, Gauteng

Department of Medical Oncology ( Site 1703), Pretoria, Gauteng

Curo Oncology ( Site 1710), Pretoria, Gauteng

Wilgers Oncology Centre ( Site 1705), Pretoria, Gauteng

Little Company of Mary Hospital ( Site 1700), Pretoria, Gauteng

Sandton Oncology Medical Group PTY LTD ( Site 1712), Sandton, Gauteng

The Oncology Centre ( Site 1709), Durban, Kwazulu-Natal

Cancercare ( Site 1706), Cape Town, Western Cape

Outeniqua Cancercare Oncology Unit ( Site 1708), George, Western Cape

Cape Town Oncology Trials Pty Ltd ( Site 1707), Kraaifontein, Western Cape

Instituto Catalan de Oncologia ICO - Hospital Duran i Reynals ( Site 1603), Hospitalet de Llobregat, Barcelona

Xarxa Assistencial Universitaria Manresa ( Site 1605), Manresa, Barcelona

Hospital de Terrassa ( Site 1606), Terrassa, Barcelona

Hospital Universitario de Donostia ( Site 1602), Donostia, Gipuzkoa

Complejo Hospitalario Universitario A Coruna. CHUAC ( Site 1608), A Coruna, La Coruna

Instituto Valenciano de Oncologia ( Site 1601), Valencia, Valenciana, Comunitat

Hospital General Universitario de Valencia ( Site 1610), Valencia, Valenciana, Comunitat

Hospital Provincial San Pedro de Alcantara ( Site 1607), Caceres, Not set

Hospital Universitario Lucus Augusti ( Site 1609), Lugo, Not set

Clinica Universitaria de Navarra ( Site 1600), Madrid, Not set

Hospital Universitario Virgen del Rocio ( Site 1604), Sevilla, Not set

Changhua Christian Hospital ( Site 2507), Changhua, Not set

China Medical University Hospital ( Site 2506), Taichung, Not set

Taichung Veterans General Hospital ( Site 2510), Taichung, Not set

National Cheng Kung University Hospital ( Site 2508), Tainan, Not set

National Taiwan University Hospital ( Site 2502), Taipei, Not set

MacKay Memorial Hospital ( Site 2500), Taipei, Not set

Taipei Veterans General Hospital ( Site 2503), Taipei, Not set

Linkou Chang Gung Memorial Hospital ( Site 2501), Taoyuan, Not set

Istanbul Acibadem University Atakent Hospital ( Site 1902), Kucukcekmece, Istanbul

Etlik Zubeyde Hanim Kadin Hastaliklari Egitim ve Arastirma Hastanesi ( Site 1903), Ankara, Not set

Ankara UTF Cebeci Arastırma ve Uygulama Hastanesi ( Site 1905), Ankara, Not set

Akdeniz Universitesi Tıp Fakultesi ( Site 1901), Antalya, Not set

Uludag Universitesi Tip Fakultesi ( Site 1904), Bursa, Not set

Istanbul Universitesi Istanbul Tip Fakultesi ( Site 1900), Istanbul, Not set

Bakirkoy Sadi Konuk Egitim ve Arastirma Hastanesi ( Site 1907), Istanbul, Not set

Medipol Universite Hastanesi ( Site 1909), Istanbul, Not set

Sakarya Universitesi Tip Fakultesi Hastanesi ( Site 1906), Sakarya, Not set

MI Precarpathian Clinical Oncology Center ( Site 2181), Ivano-Frankivsk, Ivano-Frankivska Oblast

Grigoriev Institute for medical Radiology NAMS of Ukraine ( Site 2180), Kharkiv, Kharkivska Oblast

Municipal non-profit Enterprise Khmelnytskyi Regional Antitu-Gynecological Oncology department, Poli, Khmelnytskyi, Khmelnytska Oblast

Lviv State Oncology Regional Treatment and Diagnostic Center ( Site 2170), Lviv, Lvivska Oblast

MI Odessa Regional Oncological Centre ( Site 2121), Odesa, Odeska Oblast

RMI - Sumy Regional Clinical Oncology Dispensary ( Site 2191), Sumy, Sumska Oblast

Central City Clinical Hospital ( Site 2150), Uzhgorod, Zakarpatska Oblast

Kyiv City Clinical Oncological Center ( Site 2140), Kyiv, Not set

Conditions: Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms

Learn More ›

Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)

NCT04380636

Active Not Recruiting

The purpose of this study is to assess the efficacy and safety of pembrolizumab in combination with concurrent chemoradiation therapy followed by either pembrolizumab with olaparib placebo (Arm 1) or with olaparib (Arm 2) compared to concurrent chemoradiation therapy followed by durvalumab (Arm 3) in participants with unresectable, locally advanced NSCLC. Arms 1 and 2 will be studied in a double-blind design and Arm 3 will be open-label. The primary hypotheses are: 1. Pembrolizumab with concurr... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/15/2024

Locations: University of South Alabama, Mitchell Cancer Institute ( Site 0003), Mobile, Alabama +204 locations

University of South Alabama, Mitchell Cancer Institute ( Site 0003), Mobile, Alabama

St. Bernards Medical Center ( Site 0089), Jonesboro, Arkansas

St Joseph Heritage Healthcare-Oncology ( Site 0088), Fullerton, California

Long Beach Memorial Medical Center ( Site 0006), Long Beach, California

UCLA Hematology/Oncology - Santa Monica ( Site 0013), Los Angeles, California

St. Joseph Heritage Healthcare Local Lab ( Site 0011), Santa Rosa, California

Torrance Memorial Physician Network / Cancer Center ( Site 0093), Torrance, California

Memorial Regional Hospital-Memorial Cancer Institute ( Site 0095), Hollywood, Florida

Miami VA Healthcare System ( Site 0024), Miami, Florida

Mid Florida Hematology and Oncology Center ( Site 0022), Orange City, Florida

Orlando Health, UF Health Cancer Center Inc ( Site 0092), Orlando, Florida

Fort Wayne Medical Oncology and Hematology ( Site 0094), Fort Wayne, Indiana

Parkview Research Center ( Site 0032), Fort Wayne, Indiana

Franciscan Health Lafayette East ( Site 0031), Lafayette, Indiana

University of Kentucky ( Site 0096), Lexington, Kentucky

Norton Brownsboro Hospital-Norton Cancer Institute - Brownsboro ( Site 0035), Louisville, Kentucky

Pikeville Medical Center ( Site 0036), Pikeville, Kentucky

Massachusetts General Hospital ( Site 0038), Boston, Massachusetts

Henry Ford Hospital ( Site 0045), Detroit, Michigan

VA St. Louis Health Care System ( Site 0047), Saint Louis, Missouri

Washington University Siteman Cancer Center ( Site 0046), Saint Louis, Missouri

CHI Health St. Francis ( Site 0053), Grand Island, Nebraska

Rutgers Cancer Institute of New Jersey ( Site 0054), New Brunswick, New Jersey

The Valley Hospital ( Site 0056), Paramus, New Jersey

Montefiore Einstein Center ( Site 0083), Bronx, New York

Novant Health Presbyterian ( Site 0081), Charlotte, North Carolina

Duke University Medical Center ( Site 0050), Durham, North Carolina

Piedmont Hematology-Oncology Associates ( Site 0080), Winston-Salem, North Carolina

The Lindner Center for Research and Education at The Christ Hospital ( Site 0060), Cincinnati, Ohio

Fox Chase Cancer Center ( Site 0063), Philadelphia, Pennsylvania

Sanford Cancer Center Oncology Clinic ( Site 0066), Sioux Falls, South Dakota

Veterans Affairs Puget Sound Health Care System [Seattle, WA] ( Site 0075), Seattle, Washington

Cancer Care Northwest ( Site 0074), Spokane Valley, Washington

Instituto Médico Río Cuarto ( Site 4003), Río Cuarto, Cordoba

Clinica Adventista Belgrano-Oncology ( Site 4002), Caba, Not set

Queen Elizabeth II Health Sciences Centre ( Site 0100), Halifax, Nova Scotia

Centre Hospitalier de l Universite de Montreal - CHUM ( Site 0102), Montreal, Quebec

CIUSSS Ouest de l Ile - St-Mary s Hospital ( Site 0108), Montreal, Quebec

McGill University Health Center - Research Institute ( Site 0114), Montreal, Quebec

Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus ( Site 0, Quebec, Not set

Centro Investigación del Cáncer James Lind ( Site 0202), Temuco, Araucania

OrlandiOncologia ( Site 0201), Santiago, Region M. De Santiago

Bradfordhill ( Site 0200), Santiago, Region M. De Santiago

Oncocentro ( Site 0203), Vina del Mar, Valparaiso

Bradford Hill Norte ( Site 0204), Antofagasta, Not set

Beijing Cancer Hospital ( Site 3224), Beijing, Beijing

Peking Union Medical College Hospital ( Site 3201), Beijing, Beijing

Cancer Hospital Chinese Academy of Medical Sciences ( Site 3213), Beijing, Beijing

Beijing Cancer Hospital ( Site 3212), Beijing, Beijing

Daping Hospital,Third Military Medical University ( Site 3235), Chongqing, Chongqing

Fujian Provincial Cancer Hospital ( Site 3226), Fuzhou, Fujian

The First Affiliated Hospital of Xiamen University ( Site 3219), Xiamen, Fujian

Peking University Shenzhen Hospital ( Site 3216), Shenzhen, Guangdong

Cancer Hospital Chinese Academy Of Medical Sciences. Shenzhen Center ( Site 3200), Shenzhen, Guangdong

Henan Cancer Hospital ( Site 3205), Zhengzhou, Henan

Wuhan Union Hospital ( Site 3222), Wuhan, Hubei

Hubei Cancer Hospital ( Site 3218), Wuhan, Hubei

Hunan Cancer Hospital ( Site 3238), Changsha, Hunan

Xiangya Hospital of Central South University ( Site 3637), Changsha, Hunan

Second Xiangya Hospital of Central-South University ( Site 3227), Changsha, Hunan

Hunan Cancer Hospital ( Site 3225), Changsha, Hunan

Jiangsu Cancer Hospital ( Site 3234), Nanjing, Jiangsu

The Second Affiliated Hospital of Nanchang University ( Site 3206), Nanchang, Jiangxi

Jilin Cancer Hospital ( Site 3230), Changchun, Jilin

Shanghai Chest Hospital ( Site 3207), Shangai, Shanghai

Zhongshan Hospital Fudan University ( Site 3220), Shanghai, Shanghai

Shanghai Pulmonary Hospital ( Site 3203), Shanghai, Shanghai

West China Hospital of Sichuan University ( Site 3202), Chengdu, Sichuan

Tianjin Medical University Cancer Institute & Hospital ( Site 3204), Tianjin, Tianjin

The 1st Affil Hosp of College of Medicine, Zhejiang Univ ( Site 3232), Hangzhou, Zhejiang

Masarykuv onkologicky ustav ( Site 2206), Brno, Brno-mesto

Fakultni nemocnice Ostrava ( Site 2201), Ostrava, Ostrava Mesto

Fakultni nemocnice Kralovske Vinohrady-Radioterapeuticka a onkologicka klinika ( Site 2200), PRague, Praha 10

Fakultni nemocnice v Motole ( Site 2210), Praha, Praha, Hlavni Mesto

Nemocnice Na Plesi s.r.o. ( Site 2202), Nova Ves pod Plesi, Pribram

Krajska nemocnice Liberec, a.s. ( Site 2209), Liberec, Not set

Vseobecna fakultni nemocnice v Praze ( Site 2208), Praha 2, Not set

Nemocnice Na Bulovce ( Site 2205), Praha 8, Not set

North Estonia Medical Centre Foundation ( Site 1601), Tallin, Harjumaa

Tartu University Hospital ( Site 1600), Tartu, Tartumaa

Clinique Clairval ( Site 0802), Marseille, Bouches-du-Rhone

C.H.R.U. de Brest - Hopital Morvan ( Site 0806), Brest, Bretagne

Centre Hospitalier Annecy Genevois ( Site 0811), Epagny Metz Tessy, Haute-Savoie

Clinique Teissier Groupe ( Site 0808), Valenciennes, Nord

Hopital Avicenne ( Site 0803), Bobigny, Seine-Saint-Denis

Clinique de l'Europe-Service de pneumologie ( Site 0816), Amiens, Somme

H.I.A. Sainte-Anne ( Site 0815), Toulon, Var

CHD Vendee ( Site 0807), La Roche sur Yon, Vendee

Universitätsmedizin Göttingen - Georg-August-Universität ( Site 0917), Göttingen, Niedersachsen

Johannes Wesling Klinikum Minden ( Site 0908), Minden, Nordrhein-Westfalen

GEHO Muenster ( Site 0910), Muenster, Nordrhein-Westfalen

Johanna Etienne Hospital-Klinik für Onkologie ( Site 0916), Neuss, Nordrhein-Westfalen

LungenClinic Grosshansdorf GmbH ( Site 0901), Grosshansdorf, Schleswig-Holstein

Zentralklinik Bad Berka GmbH ( Site 0905), Bad Berka, Thuringen

Universitaetsklinikum Jena ( Site 0911), Jena, Thuringen

Charite-Universitaetsmedizin Berlin Campus Virchow-Klinikum ( Site 0900), Berlin, Not set

Katholisches Marienkrankenhaus gGmbH ( Site 0902), Hamburg, Not set

Bacs-Kiskun Megyei Korhaz-Onkoradiologiai Kozpont ( Site 2302), Kecskemét, Bacs-Kiskun

Bekes Megyei Kozponti Korhaz - Pandy Kalman Tagkorhaza ( Site 2303), Gyula, Bekes

Petz Aladar Megyei Oktato Korhaz ( Site 2306), Gyor, Gyor-Moson-Sopron

Orszagos Koranyi Pulmonologiai Intezet ( Site 2305), Budapest, Not set

Országos Korányi Pulmonológiai Intézet-VI. Tüdöbelosztály és Bronchológia ( Site 2309), Budapest, Not set

Azienda Ospedaliera Umberto I- Torrette ( Site 1009), Torrette, Ancona

Azienda Ospedaliero Universitaria Careggi ( Site 1001), Florence, Firenze

Istituto Clinico Humanitas Research Hospital ( Site 1000), Rozzano, Lombardia

Azienda Ospedaliera Vito Fazzi ( Site 1003), Lecce, Not set

Fondazione IRCCS Istituto Nazionale dei Tumori di Milano ( Site 1008), Milano, Not set

Policlinico di Modena ( Site 1007), Modena, Not set

Policlinico Agostino Gemelli ( Site 1002), Roma, Not set

A.O.U. Santa Maria della Misericordia di Udine ( Site 1004), Udine, Not set

Kurume University Hospital ( Site 3112), Kurume, Fukuoka

Kobe Minimally Invasive Cancer Center ( Site 3100), Kobe, Hyogo

Kanagawa Cancer Center ( Site 3101), Yokohama, Kanagawa

Kansai Medical University Hospital ( Site 3103), Hirakata, Osaka

Osaka Medical and Pharmaceutical University Hospital ( Site 3110), Takatsuki, Osaka

National Hospital Organization Kyushu Cancer Center ( Site 3104), Fukuoka, Not set

Niigata Cancer Center Hospital ( Site 3109), Niigata, Not set

Osaka International Cancer Institute ( Site 3106), Osaka, Not set

Juntendo University Hospital ( Site 3111), Tokyo, Not set

Tokyo Metropolitan Komagome Hospital ( Site 3108), Tokyo, Not set

The Cancer Institute Hospital of JFCR ( Site 3107), Tokyo, Not set

Showa University Hospital ( Site 3105), Tokyo, Not set

Chungbuk National University Hospital ( Site 2802), Cheongju-si, Chungbuk

National Cancer Center ( Site 2800), Goyang-si, Kyonggi-do

The Catholic University of Korea St. Vincent s Hospital ( Site 2805), Gyeonggi-do, Kyonggi-do

Seoul National University Bundang Hospital ( Site 2801), Seongnam-si, Kyonggi-do

Ajou University Hospital ( Site 2803), Suwon-si, Kyonggi-do

Gyeongsang National University Hospital ( Site 2804), Jinju-si, Kyongsangnam-do

Keimyung University Dongsan Hospital ( Site 2807), Daegu, Taegu-Kwangyokshi

Kangbuk Samsung Hospital ( Site 2806), Seoul, Not set

Severance Hospital Yonsei University Health System ( Site 2808), Seoul, Not set

Pauls Stradins Clinical University Hospital ( Site 1501), Riga, Not set

Riga East Clinical University Hospital ( Site 1500), Riga, Not set

Hospital of Lithuanian University of Health Sciences Kauno klinikos-Pulmonology ( Site 4201), Kaunas, Kauno Apskritis

National Cancer Institute-Department of Thoracic Surgery and Oncology ( Site 4200), Vilnius, Vilniaus Miestas

Hospital Civil de Guadalajara Fray Antonio Alcalde ( Site 0500), Guadalajara, Jalisco

Hospital Universitario "Dr. Jose Eleuterio Gonzalez" ( Site 0508), Monterrey, Nuevo Leon

CLIMERS Clinical Medical Research ( Site 0506), Orizaba, Veracruz

Instituto Nacional de Cancerologia ( Site 0502), Tlalpan, Not set

Akershus Universitetssykehus HF ( Site 1106), Lorenskog, Akershus

Vestre Viken HF Drammen Sykehus ( Site 1101), Drammen, Buskerud

Sykehuset Oestfold ( Site 1107), Gralum, Ostfold

Helse Stavanger HF Stavanger Universitetssjukehus ( Site 1103), Stavanger, Rogaland

Oslo Universitetssykehus HF. Ulleval ( Site 1100), Oslo, Not set

Hospital Nacional Carlos Alberto Seguin Escobedo ESSALUD ( Site 0604), Arequipa, Ariqipa

Oncosalud ( Site 0605), Lima, Muni Metro De Lima

Detecta Clínica ( Site 0607), Surquillo, Muni Metro De Lima

IPOR Instituto Peruano de Oncología & Radioterapia ( Site 0606), Lima, Not set

Clinica San Gabriel ( Site 0601), Lima, Not set

Hospital Nacional Cayetano Heredia ( Site 0602), Lima, Not set

Mazowiecki Szpital Wojewódzki w Siedlcach-Siedleckie Centrum Onkologii ( Site 2404), Siedlce, Mazowieckie

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie (, Warszawa, Mazowieckie

Szpital Morski im. PCK. Szpitale Pomorskie Sp. Z o.o ( Site 2400), Gdynia, Pomorskie

SPZOZ MSWIA z Warminsko-Mazurskim Centrum Onkologii w Olsztynie ( Site 2401), Olsztyn, Warminsko-mazurskie

Spitalul Universitar de Urgenta Bucuresti ( Site 2508), Bucharest, Bucuresti

Gral Medical SRL-Medical Oncology ( Site 2511), București, Bucuresti

Institutul Oncologic Prof.Dr. Ion Chiricuta Cluj-Napoca ( Site 2506), Cluj Napoca, Cluj

S.C. Radiotherapy Center Cluj S.R.L ( Site 2503), Comuna Floresti, Cluj

Centrul de Oncologie "Sfântul Nectarie"-Medical Oncology ( Site 2510), Craiova, Dolj

Radiology Therapeutic Center-Oncology ( Site 2502), Otopeni, Ilfov

Policlinica Oncomed SRL ( Site 2504), Timisoara, Timis

S C Oncocenter Oncologie Clinica S R L-Medical Oncology ( Site 2509), Timișoara, Timis

S.C.Focus Lab Plus S.R.L ( Site 2500), Bucuresti, Not set

Spitalul Clinic Judetean De Urgenta Constanta ( Site 2501), Constanta, Not set

Institutul Regional de Oncologie Iasi ( Site 2505), Iasi, Not set

Chelyabinsk Regional Clinical Oncological Dispensary ( Site 1913), Chelyabinsk, Chelyabinskaya Oblast

MSROI named after P.A. Hertsen branch of FSBI NMRC Radiology ( Site 1903), Moscow, Moskva

Nizhniy Novgorod Region Oncology Dispensary ( Site 1914), Nizhniy Novgorod, Nizhegorodskaya Oblast

Scientific Research Oncology Institute n.a. N.N.Petrov ( Site 1905), Saint-Petersburg, Sankt-Peterburg

Medical institute named after Berezin Sergey ( Site 1906), St. Petersburg, Sankt-Peterburg

Sverdlovsk Regional Oncology Hospital ( Site 1909), Ekaterinburg, Sverdlovskaya Oblast

Republican Clinical Oncology Dispensary of Tatarstan MoH ( Site 1911), Kazan, Tatarstan, Respublika

Yaroslavl Regional SBIH Clinical Oncology Hospital ( Site 1910), Yaroslavl, Yaroslavskaya Oblast

Hospital Universitario Puerta de Hierro (Majadahonda) ( Site 1202), Majadahonda, Madrid

Hospital Universitario Quiron Madrid ( Site 1200), Pozuelo de Alarcon, Madrid

H.R.U Málaga - Hospital General ( Site 1206), Málaga, Malaga

H.U. Vall de Hebron ( Site 1201), Barcelona, Not set

Hospital Clinic de Barcelona ( Site 1204), Barcelona, Not set

Hospital Universitario Virgen Macarena ( Site 1205), Sevilla, Not set

Hospital Universitario La Fe ( Site 1203), Valencia, Not set

Chulalongkorn University ( Site 3003), Bangkok, Krung Thep Maha Nakhon

Ramathibodi Hospital. ( Site 3000), Bangkok, Krung Thep Maha Nakhon

Chiang Mai University Maharaj Nakorn Chiang Mai Hospital ( Site 3001), Chiang Mai, Not set

Srinagarind Hospital. Khon Kaen University ( Site 3002), Khon Kaen, Not set

Ankara Bilkent Sehir Hastanesi ( Site 2002), Ankara, Adana

Memorial Ankara Hastanesi ( Site 2006), Ankara, Not set

Istanbul Uni. Cerrahpasa Tip Fakultesi ( Site 2000), Istanbul, Not set

Medipol Universite Hastanesi ( Site 2003), Istanbul, Not set

Göztepe Prof. Dr. Süleyman Yalçın Şehir Hastanesi-oncology ( Site 2001), Istanbul, Not set

Ege University Medical Faculty ( Site 2005), Izmir, Not set

Medical center Medikal Plaza of Ecodnipro LLC ( Site 2107), Dnipro, Dnipropetrovska Oblast

SOGrigoriev Inst for Med Radiolgy and Oncology of NAMS of Ukraine-Clinical oncology and hematology (, Kharkiv, Kharkivska Oblast

Communal nonprofit enterprise "Kherson Regional Oncology Dispensary" of Kherson Regional Council (, Antonivka Village, Khersonska Oblast

LLC Ukrainian Center of Tomotherapy ( Site 2105), Kropyvnytskyi, Kirovohradska Oblast

Medical Center of Yuriy Spizhenko LLC.-Clinical Trial ( Site 2104), Kapitanivka Village, Kyivska Oblast

SNPE National Cancer Institute ( Site 2101), Kyiv, Kyivska Oblast

Medical Center Verum ( Site 2106), Kyiv, Kyivska Oblast

Kyiv City Clinical Oncology Center ( Site 2100), Kyiv, Not set

Weston Park Hospital ( Site 1406), Sheffield, Derbyshire

University College Hospital NHS Foundation Trust ( Site 1403), London-Camden, London, City Of

Guys and St Thomas NHS Foundation Trust ( Site 1410), London, London, City Of

Royal Marsden Hospital (Sutton) ( Site 1407), London, Surrey

Southampton General Hospital ( Site 1400), Southampton, Worcestershire

Leeds Teaching Hospitals NHS Trust ( Site 1401), Leeds, Not set

Christie NHS Foundation Trust ( Site 1409), Manchester, Not set

Conditions: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung

Learn More ›

A Rollover Study for Subjects That Have Participated in an Astellas Sponsored Linsitinib Trial

NCT02057380

Completed

The purpose of this study is to provide access to continued treatment for subjects who participated in other Astellas sponsored trials and for whom the investigator feels the subject may benefit from continued treatment.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/15/2024

Locations: Site US10004, La Jolla, California +11 locations

Conditions: Advanced Solid Tumors

Learn More ›

Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)

NCT03725059

Active Not Recruiting

The purpose of this study is to assess the efficacy and safety of pembrolizumab (MK-3475) versus placebo in combination with neoadjuvant (pre-surgery) chemotherapy and adjuvant (post-surgery) endocrine therapy in the treatment of adults who have high-risk early-stage estrogen receptor-positive, human epidermal growth factor receptor 2-negative (ER+/HER2-) breast cancer. The primary study hypotheses are: 1) pembrolizumab is superior to placebo, both in combination with the protocol-specified neo... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/15/2024

Locations: Southern Cancer Center, PC ( Site 8003), Daphne, Alabama +243 locations

Southern Cancer Center, PC ( Site 8003), Daphne, Alabama

Cancer Treatment Centers of America at Western Regional Medical Center ( Site 0001), Goodyear, Arizona

Arizona Oncology Associates PC- HOPE ( Site 8008), Tucson, Arizona

Cedars Sinai Medical Center Samuel Oschin Comp. Cancer Institute ( Site 0079), Los Angeles, California

El Camino Hospital Cancer Center ( Site 0004), Mountain View, California

Stanford Cancer Center ( Site 0072), Palo Alto, California

UC Davis Comprehensive Cancer Center ( Site 0073), Sacramento, California

University of Colorado Cancer Center ( Site 0008), Aurora, Colorado

Baptist MD Anderson Cancer Center ( Site 0014), Jacksonville, Florida

Southeastern Regional Medical Center, Inc. ( Site 0075), Newnan, Georgia

The University of Chicago Medical Center ( Site 0080), Chicago, Illinois

Orchard Healthcare Research Inc. ( Site 0020), Skokie, Illinois

Midwestern Regional Medical Center, Inc. ( Site 0077), Zion, Illinois

Goshen Center for Cancer Care ( Site 0021), Goshen, Indiana

MercyOne Waterloo Cancer Center ( Site 0016), Waterloo, Iowa

James Graham Brown Cancer Center ( Site 0022), Louisville, Kentucky

Maryland Oncology Hematology, P.A. ( Site 8007), Bethesda, Maryland

Massachusetts General Hospital ( Site 0024), Boston, Massachusetts

MGH - North Shore Cancer Center ( Site 0081), Danvers, Massachusetts

MGH Newton-Wellesley Hospital's Vernon Cancer Center ( Site 0082), Newton, Massachusetts

Henry Ford Health System ( Site 0028), Detroit, Michigan

Mayo Clinic and Medical School (Rochester) ( Site 0029), Rochester, Minnesota

St. Vincent Frontier Cancer Center ( Site 0033), Billings, Montana

Oncology Hematology West, PC dba Nebraska Cancer Specialists ( Site 0039), Omaha, Nebraska

Holy Name Medical Center ( Site 0041), Teaneck, New Jersey

Weill Cornell Medical College ( Site 0043), New York, New York

CTCA Southwestern ( Site 0074), Tulsa, Oklahoma

OHSU Knight Cancer Institute ( Site 0051), Portland, Oregon

Northwest Cancer Specialists, P.C. ( Site 8000), Tigard, Oregon

Geisinger Medical Center ( Site 0052), Danville, Pennsylvania

Fox Chase Cancer Center ( Site 0078), Philadelphia, Pennsylvania

Cancer Treatment Centers of America-Eastern Regional Medical Center ( Site 0076), Philadelphia, Pennsylvania

Medical University of South Carolina ( Site 0053), Charleston, South Carolina

Tennessee Oncology, PLLC/The Sarah Cannon Research Institute ( Site 7000), Nashville, Tennessee

Texas Oncology-Austin Central ( Site 8004), Austin, Texas

Texas Oncology-Dallas Presbyterian Hospital ( Site 8002), Dallas, Texas

Texas Oncology-Baylor Charles A. Sammons Cancer Center ( Site 8009), Dallas, Texas

Texas Oncology-Memorial City ( Site 8012), Houston, Texas

University of Texas-MD Anderson Cancer Center ( Site 0083), Houston, Texas

Texas Oncology- Plano East ( Site 8010), Plano, Texas

Texas Oncology-Tyler ( Site 8006), Tyler, Texas

Bon Secours St. Francis Medical Center Oncology Research ( Site 0064), Midlothian, Virginia

Virginia Oncology Associates ( Site 8001), Norfolk, Virginia

Kadlec Clinic Hematology and Oncology ( Site 0070), Kennewick, Washington

Medical Oncology Associates (Summit Cancer Centers) ( Site 0066), Spokane, Washington

Chris OBrien Lifehouse ( Site 2107), Camperdown, New South Wales

Royal North Shore Hospital ( Site 2100), Sydney, New South Wales

Westmead Hospital ( Site 2101), Sydney, New South Wales

Mater Misericordiae Ltd ( Site 2106), South Brisbane, Queensland

Frankston Hospital ( Site 2103), Frankston, Victoria

Peter MacCallum Cancer Centre ( Site 2102), Melbourne, Victoria

Imelda Ziekenhuis Bonheiden ( Site 0703), Bonheiden, Antwerpen

UZ Antwerpen - Medical Oncology ( Site 0709), Edegem, Antwerpen

Institut Jules Bordet ( Site 0710), Anderlecht, Bruxelles-Capitale, Region De

Cliniques Universitaires Saint-Luc ( Site 0701), Brussels, Bruxelles-Capitale, Region De

CHC MontLegia ( Site 0707), Liège, Liege

Jessa Ziekenhuis Campus Virga Jesse ( Site 0704), Hasselt, Limburg

CHU UCL Namur Site de Godinne ( Site 0706), Yvoir, Namur

AZ Maria Middelares Gent ( Site 0700), Gent, Oost-Vlaanderen

UZ Leuven ( Site 0702), Leuven, Vlaams-Brabant

AZ Groeninge ( Site 0705), Kortrijk, West-Vlaanderen

Hospital Araujo Jorge Associacao de Combate ao Cancer de Goias ( Site 0205), Goiania, Goias

ONCOSITE - Centro de Pesquisa Clinica em Oncologia ( Site 0206), Ijui, Rio Grande Do Sul

Associacao Hospitalar Moinhos de Vento ( Site 0201), Porto Alegre, Rio Grande Do Sul

Uniao Brasileira de Educacao e Assistencia Hospital Sao Lucas da Pucrs ( Site 0202), Porto Alegre, Rio Grande Do Sul

CEPON - Centro de Pesquisas Oncologicas ( Site 0208), Florianopolis, Santa Catarina

Centro de Novos Tratamentos Itajai - Clinica de Neoplasias Litoral ( Site 0207), Itajai, Santa Catarina

Núcleo de Pesquisa Clínica da Rede São Camilo ( Site 0210), São Paulo, Sao Paulo

Instituto Nacional de Cancer - INCA HC III ( Site 0200), Rio de Janeiro, Not set

Instituto do Cancer do Estado de Sao Paulo - ICESP ( Site 0209), Sao Paulo, Not set

Clinica de Pesquisas e Ctro de Estudos Onc. Ginecol. e Mamaria Ltda ( Site 0204), Sao Paulo, Not set

Cross Cancer Institute ( Site 0115), Edmonton, Alberta

BC Cancer-Vancouver Center ( Site 0116), Vancouver, British Columbia

Princess Margaret Cancer Centre ( Site 0112), Toronto, Ontario

CISSS de la Monteregie-Centre ( Site 0108), Greenfield Park, Quebec

Hopital Maisonneuve-Rosemont CIUSSS de l Est de L Ile de Montreal ( Site 0111), Montreal, Quebec

Centre Hospitalier de l Universite de Montreal - CHUM ( Site 0114), Montreal, Quebec

Jewish General Hospital ( Site 0103), Montreal, Quebec

Centre Hospitalier Regional de Trois-Rivieres ( Site 0106), Trois-Rivières, Quebec

CHU de Quebec Universite Laval - Hopital du Saint-Sacrement ( Site 0101), Quebec, Not set

Anhui Provincial Hospital ( Site 3224), Heifei, Anhui

Ruijin Hosp,Shanghai Jiao Tong University School of Medicine ( Site 3215), Shanghai, Anhui

Cancer Hospital Chinese Academy of Medical Sciences ( Site 3208), Beijing, Beijing

Fujian Medical University Union Hospital-1 Bingfanglou-Oncology ( Site 3207), Fuzhou Fujian, Fujian

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University ( Site 3213), Guangzhou, Guangdong

Fourth Hospital Of Hebei Medical University ( Site 3216), Shijia Zhuang, Hebei

Harbin Medical University Cancer Hospital ( Site 3200), Harbin, Heilongjiang

Henan Cancer Hospital ( Site 3212), Zhengzhou, Henan

Hubei Cancer Hospital ( Site 3211), Wuhan, Hubei

Hunan Cancer Hospital ( Site 3214), Changsha, Hunan

The First Affiliated Hospital of Zhejiang University ( Site 3203), Hangzhou, Jiangsu

The First Hospital of Jilin University ( Site 3201), Changchun, Jilin

Fudan University Shanghai Cancer Center ( Site 3205), Shanghai, Shanghai

The First Affiliated Hospital of Xi an Jiaotong University ( Site 3220), XI An, Shanxi

Tianjin Medical University Cancer Institute & Hospital ( Site 3209), Tianjin, Tianjin

Cancer Hospital Affiliated to Xinjiang Medical University ( Site 3219), Urumqi, Xinjiang

Zhejiang Provincial People's Hospital ( Site 3225), Hangzhou, Zhejiang

Zhejiang Cancer Hospital.... ( Site 3210), Hangzhou, Zhejiang

Clínica Vida Fundación - Sede Poblado ( Site 0405), Medellin, Antioquia

Rodrigo Botero SAS ( Site 0407), Medellin, Antioquia

Clinica de la Costa Ltda. ( Site 0400), Barranquilla, Atlantico

Oncomedica S.A. ( Site 0401), Monteria, Cordoba

Centro de Investigacion Clinica del Country ( Site 0402), Bogota, Distrito Capital De Bogota

Fundacion Universitaria Sanitas ( Site 0403), Bogota, Distrito Capital De Bogota

Centro Medico Imbanaco de Cali S.A ( Site 0406), Cali, Valle Del Cauca

Hospital Metropolitano - Sede Lindora ( Site 4203), Santa Ana, San Jose

Centre Francois Baclesse ( Site 0927), Caen, Calvados

Centre Georges Francois Leclerc ( Site 0920), Dijon, Cote-d Or

Institut Claudius Regaud IUCT Oncopole ( Site 0903), Toulouse, Haute-Garonne

Institut Curie - Centre Rene Huguenin ( Site 0917), Saint-Cloud, Hauts-de-Seine

Centre de Cancerologie du Grand Montpellier ( Site 0925), Montpellier, Herault

CHR-METZ-THIONVILLE - Hopital de Mercy ( Site 0919), Metz, Moselle

Centre Oscar Lambret ( Site 0911), Lille, Nord-Pas-de-Calais

Institut Sainte Catherine ( Site 0916), Avignon, Provence-Alpes-Cote-d Azur

Centre Jean Perrin ( Site 0909), Clermont Ferrand Cedex, Puy-de-Dome

Clinique Victor Hugo ( Site 0906), Le Mans, Sarthe

Institut Gustave Roussy ( Site 0926), Villejuif, Val-de-Marne

Institut Curie ( Site 0900), Paris, Not set

Hopital Saint-Louis ( Site 0908), Paris, Not set

Hopital Tenon ( Site 0914), Paris, Not set

Medizinische Management GmbH ( Site 1012), Friedrichshafen, Baden-Wurttemberg

Universitaetsklinikum Erlangen ( Site 1001), Erlangen, Bayern

Klinikum der Universitaet Muenchen - Grosshadern ( Site 1000), Muenchen, Bayern

Sana Klinikum Offenbach GmbH ( Site 1002), Offenbach, Hessen

HELIOS Dr. Horst Schmidt Kliniken Wiesbaden ( Site 1004), Wiesbaden, Hessen

Gynaekologisch-onkologische Praxis Hannover ( Site 1013), Hannover, Niedersachsen

Gynaekologisches Zentrum ( Site 1003), Bonn, Nordrhein-Westfalen

Kliniken Essen Mitte Gmbh Evang. Huyssens Stiftung ( Site 1006), Essen, Nordrhein-Westfalen

Frauenklinik St. Louise ( Site 1014), Paderborn, Nordrhein-Westfalen

Caritas Klinikum Saarbruecken St. Theresia ( Site 1009), Saarbruecken, Saarland

Universitaetsklinikum Carl Gustav Carus ( Site 1008), Dresden, Sachsen

MVZ Nordhausen gGmbH - Praxis Dr. Grafe ( Site 1005), Nordhausen, Thuringen

Bacs-Kiskun Megyei Korhaz ( Site 2913), Kecskemet, Bacs-Kiskun

Pecsi Tudomanyegyetem Klinikai Kozpont ( Site 2905), Pecs, Baranya

Borsod-Abauj-Zemplen Megyei Korhaz es Egyetemi OktatoKorhaz ( Site 2904), Miskolc, Borsod-Abauj-Zemplen

Szent Margit Korhaz ( Site 2901), Budapest, Not set

Orszagos Onkologiai Intezet ( Site 2908), Budapest, Not set

Uzsoki Utcai Korhaz ( Site 2902), Budapest, Not set

Debreceni Egyetem Klinikai Kozpont ( Site 2907), Debrecen, Not set

Somogy Megyei Kaposi Mor Oktato Korhaz ( Site 2915), Kaposvar, Not set

Bon Secours Hospital ( Site 1554), Cork, Not set

St. James s Hospital ( Site 1553), Dublin, Not set

HaEmek Medical Center ( Site 1712), Afula, Not set

Assuta Ashdod Public ( Site 1704), Ashdod, Not set

Soroka Medical Center ( Site 1701), Beer Sheva, Not set

Rambam Health Care Campus-Oncology Division ( Site 1705), Haifa, Not set

Shaare Zedek Medical Center ( Site 1708), Jerusalem, Not set

Hadassah Ein Karem - Sharett Institute of Oncology ( Site 1700), Jerusalem, Not set

Meir Medical Center ( Site 1710), Kfar-Saba, Not set

Holy Family Hospital ( Site 1711), Nazareth, Not set

Rabin Medical Center ( Site 1702), Petah Tikva, Not set

Chaim Sheba Medical Center. ( Site 1707), Ramat Gan, Not set

Kaplan Medical Center ( Site 1703), Rehovot, Not set

Sourasky Medical Center ( Site 1706), Tel Aviv, Not set

Assuta Medical Center ( Site 1709), Tel Aviv, Not set

Aichi Cancer Center Hospital ( Site 2601), Nagoya, Aichi

National Cancer Center Hospital East ( Site 2613), Kashiwa, Chiba

National Hospital Organization Hokkaido Cancer Center ( Site 2607), Sapporo, Hokkaido

Hyogo College of Medicine Hospital ( Site 2600), Nishinomiya, Hyogo

Kitasato University Hospital ( Site 2616), Sagamihara, Kanagawa

Saitama Medical University International Medical Center ( Site 2606), Hidaka, Saitama

Saitama Cancer Center ( Site 2612), Kitaadachi-gun, Saitama

Shizuoka Cancer Center Hospital and Research Institute ( Site 2611), Sunto-gun, Shizuoka

Chiba Cancer Center ( Site 2605), Chiba, Not set

Fukushima Medical University Hospital ( Site 2610), Fukushima, Not set

Hiroshima City Hiroshima Citizens Hospital ( Site 2603), Hiroshima, Not set

Kumamoto University Hospital ( Site 2602), Kumamoto, Not set

National Hospital Organization - Osaka National Hospital - Institute For Clinical Research ( Site 26, Osaka, Not set

Toranomon Hospital ( Site 2608), Tokyo, Not set

The Cancer Institute Hospital of JFCR ( Site 2604), Tokyo, Not set

Showa University Hospital ( Site 2615), Tokyo, Not set

National Cancer Center ( Site 2204), Goyang-si, Kyonggi-do

Asan Medical Center ( Site 2202), Songpagu, Seoul

Seoul National University Hospital ( Site 2200), Seoul, Not set

Severance Hospital Yonsei University Health System ( Site 2201), Seoul, Not set

Samsung Medical Center ( Site 2203), Seoul, Not set

Tauranga Hospital ( Site 2302), Tauranga, Bay Of Plenty

Canterbury Regional Cancer & Blood Services ( Site 2303), Christchurch, Canterbury

Capital & Coast District Health Board - Wellington Hospital ( Site 2301), Wellington, Not set

Dolnoslaskie Centrum Onkologii. ( Site 1820), Wrocław, Dolnoslaskie

Centrum Onkologii im. Prof. Franciszka Lukaszczyka ( Site 1800), Bydgoszcz, Kujawsko-pomorskie

Instytut Centrum Zdrowia Matki Polki ( Site 1821), Lodz, Lodzkie

Mazowiecki Szpital Specjalistyczny im. dr Jozefa Psarskiego ( Site 1814), Ostroleka, Mazowieckie

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie (, Warszawa, Mazowieckie

Mazowiecki Szpital Onkologiczny ( Site 1803), Wieliszew, Mazowieckie

Bialostockie Centrum Onkologii ( Site 1819), Bialystok, Podlaskie

Wojewodzkie Centrum Onkologii Copernicus ( Site 1817), Gdansk, Pomorskie

Szpitale Pomorskie Sp. z o.o. ( Site 1818), Gdynia, Pomorskie

Beskidzkie Centrum Onkologii im. Jana Pawla II ( Site 1810), Bielsko-Biala, Slaskie

Wojewodzki Szpital Specjalistyczny nr 4 w Bytomiu ( Site 1807), Bytom, Slaskie

Narodowy Instytut Onkologii - Oddzial w Gliwicach ( Site 1801), Gliwice, Slaskie

Fundacao Champalimaud ( Site 2500), Lisboa, Aveiro

CHLN Hospital Santa Maria ( Site 2501), Lisboa, Not set

Hospital Geral de Santo Antonio ( Site 2503), Porto, Not set

Inst. Portugues de Oncologia de Porto Francisco Gentil EPE ( Site 2502), Porto, Not set

UPR Comprehensive Cancer Center ( Site 6200), San Juan, Not set

Arkhangelsk Clinical Oncological Dispensary ( Site 1901), Arkhangelsk, Arkhangel Skaya Oblast

Republican Clinical Oncology Dispensary of Republic of Bashkortostan ( Site 1909), Ufa, Baskortostan, Respublika

N.N. Blokhin NMRCO ( Site 1908), Moscow, Moskva

Central Clinical Hospital with outpatient Clinic ( Site 1907), Moscow, Moskva

Medical Rehabilitation Center ( Site 1912), Moscow, Moskva

Ryazan Regional Clinical Oncology Dispensary ( Site 1910), Ryazan, Ryazanskaya Oblast

Railway Hospital of OJSC ( Site 1913), Saint Petersburg, Sankt-Peterburg

Scientific Research Oncology Institute n.a. N.N.Petrov ( Site 1900), Saint Petersburg, Sankt-Peterburg

Republican Clinical Oncology Dispensary of Tatarstan MoH ( Site 1903), Kazan, Tatarstan, Respublika

Tomsk Scientific Research Institute of Oncology ( Site 1905), Tomsk, Tomskaya Oblast

Instituto Catalan de Oncologia ICO - Hospital Duran i Reynals ( Site 1363), Hospitalet de Llobregat, Barcelona

Hospital Teresa Herrera - Chuac ( Site 1358), A Coruna, La Coruna

Hospital General Universitario Gregorio Maranon ( Site 1367), Madrid, Madrid, Comunidad De

Hospital Quiron de Madrid ( Site 1351), Pozuelo de Alarcon, Madrid

Hospital Clinico Universitario de Valencia ( Site 1355), Valencia, Valenciana, Comunitat

Instituto Oncologico Baselga.Hospital Quiron. ( Site 1352), Barcelona, Not set

Hospital Vall D Hebron ( Site 1357), Barcelona, Not set

Hospital Clinic I Provincial de Barcelona ( Site 1353), Barcelona, Not set

Complejo Hospitalario de Jaen ( Site 1364), Jaen, Not set

Hospital Ruber Internacional ( Site 1370), Madrid, Not set

Hospital Clinico San Carlos ( Site 1354), Madrid, Not set

Hospital Universitario 12 de Octubre ( Site 1356), Madrid, Not set

Hospital Universitario Virgen del Rocio ( Site 1360), Sevilla, Not set

Hospital General Arnau de Vilanova de Valencia ( Site 1369), Valencia, Not set

China Medical University Hospital ( Site 2401), Taichung, Not set

National Cheng Kung University Hospital ( Site 2400), Tainan, Not set

National Taiwan University Hospital ( Site 2404), Taipei, Not set

Koo Foundation Sun Yat-Sen Cancer Center ( Site 2403), Taipei, Not set

Linkou Chang Gung Memorial Hospital ( Site 2402), Taoyuan, Not set

Dnipropetrovsk City Multidiscipline Clinical Hosp. 4 of DRC ( Site 2702), Dnipro, Dnipropetrovska Oblast

MI Kryviy Rih Center of Dnipropetrovsk Regional Council ( Site 2700), Kryviy Rih, Dnipropetrovska Oblast

MI Precarpathian Clinical Oncology Center ( Site 2707), Ivano-Frankivsk, Ivano-Frankivska Oblast

Communal non profit enterprise Regional Clinical Oncology Center ( Site 2721), Kharkiv, Kharkivska Oblast

Communal nonprofit enterprise "Kherson Regional Oncology Dispensary" of Kherson Regional Council (, Antonivka Village, Khersonska Oblast

Khmelnitskiy Regional Onkology Dispensary ( Site 2704), Khmelnitskiy, Khmelnytska Oblast

National Cancer Institute of the MoH of Ukraine ( Site 2719), Kyiv, Kyivska Oblast

MI Odesa Regional Clinical Hospital ( Site 2701), Odesa, Odeska Oblast

MI Odessa Regional Oncological Centre ( Site 2714), Odesa, Odeska Oblast

Medical center of the Limited Liability Company Yulis ( Site 2720), Zaporizhzhia, Zaporizka Oblast

Kyiv City Clinical Oncology Centre ( Site 2716), Kyiv, Not set

University Hospitals Bristol NHS Foundation Trust ( Site 1503), Bristol, Bristol, City Of

Nottingham University Hospitals NHS Trust ( Site 1504), Nottingham, England

Colchester General Hospital ( Site 1508), Colchester, Essex

Barts Health NHS Trust ( Site 1500), London, London, City Of

Guy's Hospital ( Site 1501), London, London, City Of

St. Georges University Hospital NHS Foundation Trust ( Site 1505), London, London, City Of

Birmingham & Solihull Heartlands Hospital NHS ( Site 1506), Solihull, Not set

Royal Cornwall Hospital ( Site 1502), Truro, Not set

Conditions: Breast Cancer

Learn More ›

Study of IDE397 in Participants With Solid Tumors Harboring MTAP Deletion

NCT04794699

Recruiting

This is a Phase 1, open-label, multicenter, dose escalation and expansion study of the safety, PK, PD, and preliminary anti-tumor activity of IDE397 as a single agent and in combination with other anticancer agents including taxanes (docetaxel, paclitaxel), or sacituzumab govitecan (SG), in adult patients with selected advanced or metastatic MTAP-deleted advanced solid tumors who are unresponsive to standard of care therapy. IDE397 is a small molecule inhibitor of methionine adenosyltransferase... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/15/2024

Locations: Honor Health Research Institute, Scottsdale, Arizona +37 locations

Honor Health Research Institute, Scottsdale, Arizona

University of Arkansas for Medical Sciences, Little Rock, Arkansas

City of Hope, Duarte, California

Providence Medical Group, Santa Rosa, California

Advent Health, Celebration, Florida

Orlando Health Cancer Institute, Orlando, Florida

Indiana University Health Hospital, Indianapolis, Indiana

Markey Cancer Center, Lexington, Kentucky

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland

Dana Farber Cancer Institute, Boston, Massachusetts

Barbara Ann Karmanos Cancer Institute, Detroit, Michigan

Columbia University Medical Center - Herbert Irving Pavilion, New York, New York

Weill Cornell Medical College, New York, New York

Stephenson Cancer Center, Oklahoma City, Oklahoma

LifeSpan - Brown University, Providence, Rhode Island

SCRI Oncology Partners, Nashville, Tennessee

MD Anderson, Houston, Texas

Next Oncology, San Antonio, Texas

Swedish Cancer Institute, Seattle, Washington

The Kinghorn Cancer Centre, St Vincent's Health Network Sydney, Darlinghurst, New South Wales

Southern Oncology Clinical Research Unit, Bedford Park, South Australia

Institut Bergonie, Bordeaux, Bordeaux Cedex

Institut Claudius Regaud - IUCT-Oncopole, Toulouse, Cedex 9

Hôpital Timone, Marseille, Not set

Centre Eugène Marquis, Rennes, Not set

Universitaetsklinikum Hamburg-Eppendorf (UKE), Hamburg, Not set

Chungbuk National University Hospital, Cheongju-si, Chungcheongbuk-Do

National Cancer Center, Goyang-si, Gyeonggi

CHA University - Bundang Medical Center, Seongnam-si, Gyeonggi

Sevrance Hospital, Seoul, Not set

Asan Medical Center, Seoul, Not set

Vall Hebron Institute of Oncology, Barcelona, Not set

Hospital Universitario 12 de Octubre (H12O), Madrid, Not set

START Madrid-HM - Centro Integral Oncológico Clara Campal (CIOCC), Madrid, Not set

NEXT Madrid, Universitary Hospital QuironSAlud, Madrid, Not set

Instituto Valenciano de Oncología (IVO), Valencia, Not set

National Cheng Kung University Hospital, Tainan, Not set

National Taiwan University Hospital, Taipei, Not set

Conditions: Solid Tumor

Learn More ›

Study of Pembrolizumab (MK-3475) Subcutaneous (SC) Versus Pembrolizumab Intravenous (IV) Administered With Platinum Doublet Chemotherapy in Participants With Metastatic Squamous or Nonsquamous Non-Small Cell Lung Cancer (NSCLC) (MK-3475-A86)

NCT04956692

Active Not Recruiting

The purpose of this study is to evaluate pembrolizumab (MK-3475) subcutaneous (SC) administration as the first-line therapy in the treatment of metastatic squamous and nonsquamous NSCLC by assessing the pharmacokinetics (PK), safety, and efficacy of pembrolizumab SC injection in combination with standard-of-care chemotherapy. The primary hypothesis of the study is Pembrolizumab SC is noninferior to pembrolizumab intravenous (IV) for Cycle 1 Area Under Curve (AUC) and Cycle 6 minimal concentratio... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/14/2024

Locations: St. Bernards Medical Center ( Site 0103), Jonesboro, Arkansas +125 locations

St. Bernards Medical Center ( Site 0103), Jonesboro, Arkansas

St Joseph Heritage Healthcare-Oncology ( Site 0102), Fullerton, California

Cancer Blood and Specialty Clinic ( Site 0105), Los Alamitos, California

PIH Health Hematology Medical Oncology ( Site 0106), Whittier, California

Holy Cross Hospital ( Site 0017), Fort Lauderdale, Florida

Memorial Regional Hospital-Memorial Cancer Institute ( Site 0104), Hollywood, Florida

Advent Health ( Site 0013), Orlando, Florida

Fort Wayne Medical Oncology and Hematology ( Site 0101), Fort Wayne, Indiana

Baptist Health Lexington ( Site 0099), Lexington, Kentucky

St Luke's Hospital - Kansas City ( Site 0033), Kansas City, Missouri

St. Vincent Frontier Cancer Center ( Site 0058), Billings, Montana

Montefiore Medical Center [Bronx, NY] ( Site 0040), Bronx, New York

The University of Tennessee Medical Center ( Site 0050), Knoxville, Tennessee

Tennessee Oncology ( Site 0051), Nashville, Tennessee

Oncology Consultants, PA ( Site 0052), Houston, Texas

Millennium Physicians - Oncology ( Site 0097), Houston, Texas

Oncology & Hematology Assoc. SW Virginia, Inc., DBA Blue Ridge Cancer Care ( Site 0100), Blacksburg, Virginia

West Virginia University ( Site 0056), Morgantown, West Virginia

HOSPITAL EVANGÉLICO DE CACHOEIRO DE ITAPEMIRIM ( Site 0307), Cachoeiro de Itapemirim, Espirito Santo

Hospital Sao Vicente de Paulo ( Site 0311), Passo Fundo, Rio Grande Do Sul

Instituto Joinvilense de Hematologia e Oncologia ( Site 0308), Joinville, Santa Catarina

Fundacao Faculdade Regional de Medicina de Sao Jose do Rio Preto ( Site 0305), Sao Jose do Rio Preto, Sao Paulo

Núcleo de Pesquisa Clínica da Rede São Camilo ( Site 0304), São Paulo, Sao Paulo

Nouvel Hôpital Civil (NHC) ( Site 1018), Strasbourg, Bas-Rhin

CHU Limoges CHU Dupuytren ( Site 1011), Limoges, Haute-Vienne

Hôpital Foch ( Site 1019), Suresnes, Hauts-de-Seine

Institut Regional du Cancer de Montpellier - ICM ( Site 1003), Montpellier, Herault

Centre Hospitalier Sud Réunion ( Site 1020), Saint-Pierre, La Reunion

Hopital Guillaume & Rene Laennec ( Site 1007), Saint-Herblain, Loire-Atlantique

Centre Hospitalier de Pau ( Site 1016), Pau, Pyrenees-Atlantiques

CHU de Rouen ( Site 1013), Rouen, Seine-Maritime

Hopital Cochin ( Site 1002), Paris, Not set

Centro de Investigaciones Clinicas de Latinoamerica S.A. - CELAN ( Site 0602), Guatemala, Not set

Clinica Privada Dr. Rixci Ramirez ( Site 0601), Guatemala, Not set

INTERVASC ( Site 0605), Guatemala, Not set

Grupo Angeles SA ( Site 0604), Guatemala, Not set

Centro Regional de Sub Especialidades Médicas SA ( Site 0600), Quetzaltenango, Not set

Bacs-Kiskun Megyei Korhaz-Onkoradiologiai Kozpont ( Site 1106), Kecskemét, Bacs-Kiskun

Petz Aladar Megyei Oktato Korhaz ( Site 1110), Gyor, Gyor-Moson-Sopron

Jasz Nagykun Szolnok Megyei Hetenyi Geza Korhaz Rendelointezet ( Site 1103), Szolnok, Jasz-Nagykun-Szolnok

Tudogyogyintezet Torokbalint ( Site 1105), Torokbalint, Pest

Veszprem Megyei Tudogyogyintezet ( Site 1108), Farkasgyepu, Veszprem

Zala Megyei Szent Rafael Korhaz ( Site 1111), Zalagerszeg, Zalaegerszeg

Semmelweis University-Pulmonológiai Klinika ( Site 1114), Budapest, Not set

Orszagos Koranyi Pulmonologiai Intezet ( Site 1104), Budapest, Not set

Fujita Health University Hospital ( Site 3007), Toyoake, Aichi

Ehime University Hospital ( Site 3005), Toon, Ehime

Kurume University Hospital ( Site 3006), Kurume, Fukuoka

National Hospital Organization Hokkaido Cancer Center ( Site 3014), Sapporo, Hokkaido

Kanazawa University Hospital ( Site 3004), Kanazawa, Ishikawa

Kanagawa Cardiovascular and Respiratory Center ( Site 3003), Yokohama, Kanagawa

Miyagi Cancer Center ( Site 3000), Natori, Miyagi

Sendai Kousei Hospital ( Site 3015), Sendai, Miyagi

Kurashiki Central Hospital ( Site 3013), Kurashiki, Okayama

Kansai Medical University Hospital ( Site 3016), Hirakata, Osaka

National Hospital Organization Kinki-chuo Chest Medical Center ( Site 3009), Sakai, Osaka

Osaka Medical and Pharmaceutical University Hospital ( Site 3017), Takatsuki, Osaka

Chiba University Hospital ( Site 3008), Chiba, Not set

National Hospital Organization Kyushu Medical Center ( Site 3001), Fukuoka, Not set

National Hospital Organization Kyushu Cancer Center ( Site 3002), Fukuoka, Not set

Okayama University Hospital ( Site 3012), Okayama, Not set

Osaka International Cancer Institute ( Site 3018), Osaka, Not set

Tokushima University Hospital ( Site 3019), Tokushima, Not set

Juntendo University Hospital ( Site 3011), Tokyo, Not set

Showa University Hospital ( Site 3010), Tokyo, Not set

Chungnam National University Hospital ( Site 2002), Daejeon, Chungnam

Chonnam National University Hwasun Hospital-Pulmonology ( Site 2000), Hwasun, Jeonranamdo

Korea University Guro Hospital ( Site 2003), Seoul, Not set

Hospital Nacional Carlos Alberto Seguin Escobedo ESSALUD ( Site 0704), Arequipa, Ariqipa

Clínica Peruano-Americana de Trujillo ( Site 0701), Trujillo, La Libertad

Oncosalud ( Site 0706), Lima, Muni Metro De Lima

Clinica Internacional Sede San Borja ( Site 0705), Lima, Not set

Instituto Nacional de Enfermedades Neoplasicas ( Site 0703), Lima, Not set

Hospital Nacional Cayetano Heredia ( Site 0700), Lima, Not set

Centrum Onkologii im prof Franciszka Lukaszczyka ( Site 1201), Bydgoszcz, Kujawsko-pomorskie

Mazowiecki Szpital Wojewódzki w Siedlcach-Siedleckie Centrum Onkologii ( Site 1206), Siedlce, Mazowieckie

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie (, Warszawa, Mazowieckie

Centrum Pulmonologii i Torakochirurgii w Bystrej ( Site 1205), Bystra, Slaskie

Przychodnia Lekarska KOMED ( Site 1202), Konin, Wielkopolskie

Szpital Wojewodzki im. Mikolaja Kopernika ( Site 1200), Koszalin, Zachodniopomorskie

Cardiomed SRL Cluj-Napoca ( Site 1313), Cluj-Napoca, Cluj

Institutul Oncologic Prof.Dr. Ion Chiricuta Cluj-Napoca ( Site 1303), Cluj-Napoca, Cluj

SC Radiotherapy Center Cluj SRL ( Site 1307), Comuna Floresti, Cluj

S.C. Centrul de Oncologie Sf. Nectarie SRL ( Site 1304), Craiova, Dolj

Centrul de Oncologie Oncolab-Medical Oncology ( Site 1312), Craiova, Dolj

Spitalul Municipal Ploiesti ( Site 1308), Ploiesti, Prahova

Policlinica Oncomed SRL ( Site 1302), Timisoara, Timis

S.C.Focus Lab Plus S.R.L ( Site 1301), Bucuresti, Not set

Spitalul Universitar de Urgenta Bucuresti ( Site 1305), Bucuresti, Not set

SPBU Clinic of Advanced medical technologies n.a. N. I. Pirogov ( Site 1406), Saint-Petersburg, Sankt-Peterburg

National Medical Research Center of Oncology N.A. N.N. Petrov ( Site 1407), Saint-Petersburg, Sankt-Peterburg

Saint-Petersburg Scientific-Practical Center of Specialized Kinds of Medical Care (o) ( Site 1424), Saint-Petersburg, Sankt-Peterburg

Republican Clinical Oncology Dispensary-Chemotherapy #1 ( Site 1425), Kazan, Tatarstan, Respublika

SPb SBHI City Clinical Oncological Dispensary ( Site 1409), Sankt-Peterburg, Not set

Wits Clinical Research ( Site 1510), Johannesburg, Gauteng

Steve Biko Academic Hospital ( Site 1506), Pretoria, Gauteng

Marry Potter Oncology Centre ( Site 1502), Pretoria, Gauteng

Sandton Oncology Medical Group PTY LTD ( Site 1505), Sandton, Gauteng

Chris Hani Baragwanath Academic Hospital-Wits Clinical Research Bara ( Site 1513), Soweto, Gauteng

The Oncology Centre ( Site 1507), Durban, Limpopo

Cape Town Oncology Trials Pty Ltd ( Site 1500), Kraaifontein, Western Cape

Hospital Insular de Gran Canaria-Oncology ( Site 1604), Las Palmas de Gran Canaria, Las Palmas

H.U. Vall de Hebron ( Site 1600), Barcelona, Not set

Hospital Juan Ramon Jimenez ( Site 1602), Huelva, Not set

Hospital Universitario Lucus Augusti ( Site 1603), Lugo, Not set

Hospital Universitario La Paz ( Site 1601), Madrid, Not set

Changhua Christian Hospital ( Site 2104), Changhua, Not set

National Taiwan University Hospital Hsin-Chu Branch ( Site 2103), Hsinchu, Not set

Kaohsiung Medical University Chung-Ho Memorial Hospital ( Site 2107), Kaohsiung, Not set

National Cheng Kung University Hospital ( Site 2105), Tainan, Not set

National Taiwan University Hospital ( Site 2101), Taipei, Not set

Taipei Veterans General Hospital ( Site 2106), Taipei, Not set

Chang Gung Medical Foundation-Linkou Branch ( Site 2102), Taoyuan, Not set

Gulhane Egitim ve Arastirma Hastanesi ( Site 1704), Ankara, Not set

Ankara Sehir Hastanesi ( Site 1702), Ankara, Not set

TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 1701), Istanbul, Not set

Ege Universitesi Tip Fakultesi Hastanesi ( Site 1703), Izmir, Not set

Inonu Universitesi Turgut Ozal Tip Merkezi ( Site 1707), Malatya, Not set

Medical Center Mriya Med-Service ( Site 1805), Kryvyi Rih, Dnipropetrovska Oblast

Communal non profit enterprise Regional Clinical Oncology Center ( Site 1806), Kharkiv, Kharkivska Oblast

Ukrainian Center of Tomotherapy ( Site 1807), Kropyvnytskyi, Kirovohradska Oblast

Medical Center Asklepion LLC ( Site 1804), Khodosivka, Kyivska Oblast

Municipal non-profit enterprise'Odesa Regional Clinical Hosp-Thoracic surgery department. ( Site 181, Odesa, Odeska Oblast

Kremenchuk Regional Oncology Center ( Site 1811), Kremenchuk, Poltavska Oblast

Kyiv City Clinical Oncology Centre ( Site 1809), Kyiv, Not set

Medical Center Dobrobut Clinic ( Site 1808), Kyiv, Not set

Conditions: Non-Small Cell Lung Cancer

Learn More ›

ATEMPT 2.0: Adjuvant T-DM1 Vs TH

NCT04893109

Recruiting

This research study is studying how well newly diagnosed breast cancer that has tested positive for a protein called HER2 responds using one of two different combination of HER2-directed therapies as a treatment after surgery. The name of the study drugs involved are: * Trastuzumab-emtansine (T-DM1, Kadcyla) * Trastuzumab SC (Herceptin Hylecta) * Paclitaxel

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/13/2024

Locations: UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California +48 locations

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California

Smilow Cancer Hospital Care center at Derby, Derby, Connecticut

Smilow Cancer Hospital Care center at Fairfield, Fairfield, Connecticut

Smilow Cancer Hospital Care center at Glastonbury, Glastonbury, Connecticut

Smilow Cancer Hospital Care center at Greenwich, Greenwich, Connecticut

Smilow Cancer Hospital Care center at Guilford, Guilford, Connecticut

Smilow Cancer Hospital Care center at St. Francis, Hartford, Connecticut

Smilow Cancer Hospital Care center at Long Ridge, Long Ridge, Connecticut

Yale Cancer Center at Yale University School of Medicine, New Haven, Connecticut

Smilow Cancer Hospital Care center at North Haven, North Haven, Connecticut

Stamford Hospital, Stamford, Connecticut

Smilow Cancer Hospital Care center at Torrington, Torrington, Connecticut

Smilow Cancer Hospital Care center at Trumbull, Trumbull, Connecticut

Smilow Cancer Hospital Care center at Waterbury, Waterbury, Connecticut

Smilow Cancer Hospital Care center at Waterford, Waterford, Connecticut

Miami Cancer Institute/Baptist Hospital of Miami, Miami, Florida

Miami Cancer Institute - Plantation (MCIP), Plantation, Florida

Indiana University Health Joe & Shelly Schwarz Cancer Center, Carmel, Indiana

IU Health North Hospital, Carmel, Indiana

Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana

Indiana University Sidney and Lois Eskenazi Hospital, Indianapolis, Indiana

Eastern Maine Medical Center (Northern Light), Brewer, Maine

New England Cancer Specialists, Scarborough, Maine

Beth Israel Deaconess Medical Center, Boston, Massachusetts

Dana Farber Cancer Institute, Boston, Massachusetts

Massachusetts General Hospital, Boston, Massachusetts

Dana-Farber at St. Elizabeth's Medical Center, Brighton, Massachusetts

Mass General North Shore Cancer Center, Danvers, Massachusetts

Dana-Farber Brigham Cancer Center - Foxborough, Foxborough, Massachusetts

Dana-Farber Cancer Instiute - Merrimack Valley, Methuen, Massachusetts

Dana-Farber at Milford, Milford, Massachusetts

Newton Wellesley Hospital, Newton, Massachusetts

Berkshire Medical Center, Pittsfield, Massachusetts

Dana Farber at South Shore Hospital, Weymouth, Massachusetts

NH Oncology-Hematology, PA - Payson Center for Cancer Care, Concord, New Hampshire

Dana-Farber Cancer Insitute at Londonderry Hospital, Londonderry, New Hampshire

Solinsky Center for Cancer Care (NH Oncology-Hematology, PA), Manchester, New Hampshire

New England Cancer Specialists - Portsmouth, Portsmouth, New Hampshire

New York University Langone Hospital -Brooklyn, Brooklyn, New York

New York University Langone Hospital - Long Island, Mineola, New York

New York University Langone Health, New York, New York

Duke University Medical Center, Durham, North Carolina

Duke Women's Cancer Care Raleigh, Raleigh, North Carolina

Stefanie Spielman Comprehensive Breast Center, Columbus, Ohio

University of Pennsylvania, Abramson Cancer Center, Philadelphia, Pennsylvania

Smilow Cancer Hospital Care center at Westerly, Westerly, Rhode Island

SCRI Oncology Partners, Nashville, Tennessee

Tennessee Oncology - Nashville, Nashville, Tennessee

MD Anderson Cancer Center, Houston, Texas

Conditions: Breast Cancer, HER2-positive Breast Cancer

Learn More ›

A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors

NCT02009449

Completed

This is a first-in-human, open-label, dose escalation study to evaluate the safety and tolerability of pegilodecakin in participants with advanced solid tumors, dosed daily subcutaneously as a monotherapy or in combination with chemotherapy or immunotherapy.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/13/2024

Locations: UCLA Medical Hematology & Oncology, Los Angeles, California +9 locations

Conditions: Melanoma, Prostate Cancer, Ovarian Cancer, Renal Cell Carcinoma, Colorectal Carcinoma, Pancreatic Carcinoma, Non-small Cell Lung Carcinoma, Solid Tumors, Breast Cancer

Learn More ›

Browse by State

Paclitaxel treatment options in Alabama

Paclitaxel treatment options in Alaska

Paclitaxel treatment options in Arizona

Paclitaxel treatment options in Arkansas

Paclitaxel treatment options in California

Paclitaxel treatment options in Colorado

Paclitaxel treatment options in Connecticut

Paclitaxel treatment options in Delaware

Paclitaxel treatment options in District of Columbia

Paclitaxel treatment options in Florida

Paclitaxel treatment options in Georgia

Paclitaxel treatment options in Hawaii

Paclitaxel treatment options in Idaho

Paclitaxel treatment options in Illinois

Paclitaxel treatment options in Indiana

Paclitaxel treatment options in Iowa

Paclitaxel treatment options in Kansas

Paclitaxel treatment options in Kentucky

Paclitaxel treatment options in Louisiana

Paclitaxel treatment options in Maine

Paclitaxel treatment options in Montana

Paclitaxel treatment options in Nebraska

Paclitaxel treatment options in Nevada

Paclitaxel treatment options in New Hampshire

Paclitaxel treatment options in New Jersey

Paclitaxel treatment options in New Mexico

Paclitaxel treatment options in New York

Paclitaxel treatment options in North Carolina

Paclitaxel treatment options in North Dakota

Paclitaxel treatment options in Ohio

Paclitaxel treatment options in Oklahoma

Paclitaxel treatment options in Oregon

Paclitaxel treatment options in Maryland

Paclitaxel treatment options in Massachusetts

Paclitaxel treatment options in Michigan

Paclitaxel treatment options in Minnesota

Paclitaxel treatment options in Mississippi

Paclitaxel treatment options in Missouri

Paclitaxel treatment options in Pennsylvania

Paclitaxel treatment options in Rhode Island

Paclitaxel treatment options in South Carolina

Paclitaxel treatment options in South Dakota

Paclitaxel treatment options in Tennessee

Paclitaxel treatment options in Texas

Paclitaxel treatment options in Utah

Paclitaxel treatment options in Vermont

Paclitaxel treatment options in Virginia

Paclitaxel treatment options in Washington

Paclitaxel treatment options in West Virginia

Paclitaxel treatment options in Wisconsin

Paclitaxel treatment options in Wyoming